Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88318 | Target Info | |||
Target Name | Protein kinase C (PRKC) | ||||
Target Type | Clinical trial Target | ||||
Gene Name | NO-GeName | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | BDNF/NT-3 growth factors receptor (TrkB) | Successful Target | ||||
UniProt ID | NTRK2_HUMAN | |||||
Gene Name | NTRK2 | |||||
Synonyms |
Tropomyosin-related kinase B; TrkB tyrosine kinase; Trk-B; TRKB; Neurotrophic tyrosine kinase receptor type 2; GP145-TrkB
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.0636 nM | [1] | ||
Co-Target Name | Proto-oncogene c-Ros (ROS1) | Successful Target | ||||
UniProt ID | ROS1_HUMAN | |||||
Gene Name | ROS1 | |||||
Synonyms |
c-Ros receptor tyrosine kinase; Receptor tyrosine kinase c-ros oncogene 1; ROS; Proto-oncogene tyrosine-protein kinase ROS; Proto-oncogene c-Ros-1; MCF3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.07 nM | [2] | ||
Co-Target Name | Janus kinase 3 (JAK-3) | Successful Target | ||||
UniProt ID | JAK3_HUMAN | |||||
Gene Name | JAK3 | |||||
Synonyms |
Tyrosine-protein kinase JAK3; Leukocyte janus kinase; L-JAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.1 nM | [3] | ||
Co-Target Name | Platelet-derived growth factor receptor alpha (PDGFRA) | Successful Target | ||||
UniProt ID | PGFRA_HUMAN | |||||
Gene Name | PDGFRA | |||||
Synonyms |
RHEPDGFRA; Platelet-derived growth factor receptor 2; Platelet-derived growth factor alpha receptor; PDGFR2; PDGFR-alpha; PDGFR-2; PDGF-R-alpha; CD140a antigen; CD140a; CD140 antigen-like family member A; Alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 0.1 nM | [4] | ||
Co-Target Name | Tyrosine-protein kinase SYK (SYK) | Successful Target | ||||
UniProt ID | KSYK_HUMAN | |||||
Gene Name | SYK | |||||
Synonyms |
p72-Syk; Spleen tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 0.1 nM | [4] | ||
Co-Target Name | Fms-like tyrosine kinase 3 (FLT-3) | Successful Target | ||||
UniProt ID | FLT3_HUMAN | |||||
Gene Name | FLT3 | |||||
Synonyms |
Stem cell tyrosine kinase 1; STK1; STK-1; Receptor-type tyrosine-protein kinase FLT3; Fetal liver kinase-2; FLT-3; FLK2; FLK-2; FL cytokine receptor; CD135
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.18 nM | [5] | ||
Co-Target Name | Janus kinase 2 (JAK-2) | Successful Target | ||||
UniProt ID | JAK2_HUMAN | |||||
Gene Name | JAK2 | |||||
Synonyms |
Tyrosine-protein kinase JAK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.189 nM | [1] | ||
Co-Target Name | NT-3 growth factor receptor (TrkC) | Successful Target | ||||
UniProt ID | NTRK3_HUMAN | |||||
Gene Name | NTRK3 | |||||
Synonyms |
TrkC tyrosine kinase; Trk-C; TRKC; Neurotrophic tyrosine kinase receptor type 3; NT3 growth factor receptor; GP145TrkC; GP145-TrkC
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.22 nM | [1] | ||
Co-Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | ||||
UniProt ID | EGFR_HUMAN | |||||
Gene Name | EGFR | |||||
Synonyms |
Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.29 nM | [6] | ||
Co-Target Name | Proto-oncogene c-Ret (RET) | Successful Target | ||||
UniProt ID | RET_HUMAN | |||||
Gene Name | RET | |||||
Synonyms |
RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.46 nM | [4] | ||
Co-Target Name | Tropomyosin-related kinase A (TrkA) | Successful Target | ||||
UniProt ID | NTRK1_HUMAN | |||||
Gene Name | NTRK1 | |||||
Synonyms |
gp140trk; Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; Neurotrophic tyrosine kinase receptor type 1; NGF-trk receptor type A; MTC; High affinity nerve growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.5 nM | [7] | ||
Co-Target Name | Platelet-derived growth factor receptor beta (PDGFRB) | Successful Target | ||||
UniProt ID | PGFRB_HUMAN | |||||
Gene Name | PDGFRB | |||||
Synonyms |
Platelet-derived growth factor receptor 1; PDGFR1; PDGFR-beta; PDGFR-1; PDGFR; PDGF-R-beta; CD140b antigen; CD140b; CD140 antigen-like family member B; Beta-type platelet-derived growth factor receptor; Beta-PDGFR; Beta platelet-derived growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.6 nM | [7] | ||
Co-Target Name | Janus kinase 1 (JAK-1) | Successful Target | ||||
UniProt ID | JAK1_HUMAN | |||||
Gene Name | JAK1 | |||||
Synonyms |
Tyrosine-protein kinase JAK1; JAK1B; JAK1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.627 nM | [1] | ||
Co-Target Name | Rho-associated protein kinase 1 (ROCK1) | Successful Target | ||||
UniProt ID | ROCK1_HUMAN | |||||
Gene Name | ROCK1 | |||||
Synonyms |
Rok; Rho-associated, coiled-coil containing protein kinase 1; Rho-associated kinase 1; Rho kinase; ROCK1; ROCK; P160ROCK; P160(rock); P160 ROCK-1; Let-502 kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.64 nM | [3] | ||
Co-Target Name | ALK tyrosine kinase receptor (ALK) | Successful Target | ||||
UniProt ID | ALK_HUMAN | |||||
Gene Name | ALK | |||||
Synonyms |
CD246; Anaplastic lymphoma kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.67 nM | [8] | ||
Co-Target Name | Proto-oncogene c-Src (SRC) | Successful Target | ||||
UniProt ID | SRC_HUMAN | |||||
Gene Name | SRC | |||||
Synonyms |
pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.83 nM | [9] | ||
Co-Target Name | Tyrosine-protein kinase Kit (KIT) | Successful Target | ||||
UniProt ID | KIT_HUMAN | |||||
Gene Name | KIT | |||||
Synonyms |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 ~ 1 nM | [10] | ||
Co-Target Name | LCK tyrosine protein kinase (LCK) | Successful Target | ||||
UniProt ID | LCK_HUMAN | |||||
Gene Name | LCK | |||||
Synonyms |
p56-LCK; Tyrosine-protein kinase Lck; T cell-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK; Proto-oncogene Lck; Protein YT16; Lymphocyte cell-specific protein-tyrosine kinase; Leukocyte C-terminal Src kinase; LSK; LCK p59-Fyn; LCK Protooncogene Syn
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.01 nM | [3] | ||
Co-Target Name | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | ||||
UniProt ID | VGFR2_HUMAN | |||||
Gene Name | KDR | |||||
Synonyms |
VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.2 nM | [11] | ||
Co-Target Name | Fibroblast growth factor receptor 2 (FGFR2) | Successful Target | ||||
UniProt ID | FGFR2_HUMAN | |||||
Gene Name | FGFR2 | |||||
Synonyms |
Keratinocyte growth factor receptor 2; Keratinocyte growth factor receptor; KSAM; KGFR; K-sam; FGFR-2; FGF-2 receptor; CD332; BEK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.77 nM | [12] | ||
Co-Target Name | Fyn tyrosine protein kinase (FYN) | Successful Target | ||||
UniProt ID | FYN_HUMAN | |||||
Gene Name | FYN | |||||
Synonyms |
Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene c-Fyn; Proto-oncogene Syn; Fyn p59-Fyn; Fyn Protooncogene Syn
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2 nM | [13] | ||
Co-Target Name | Platelet-derived growth factor receptor (PDGFR) | Successful Target | ||||
UniProt ID | PGFRA_HUMAN; PGFRB_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
Platelet-derived growth factor receptor tyrosine kinase; PDGFR kinase; PDGF-R
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2 nM | [14] | ||
Co-Target Name | Glycogen synthase kinase-3 alpha (GSK-3A) | Successful Target | ||||
UniProt ID | GSK3A_HUMAN | |||||
Gene Name | GSK3A | |||||
Synonyms |
Serine/threonineprotein kinase GSK3A; Serine/threonine-protein kinase GSK3A; Glycogen synthase kinase3 alpha; Glycogen synthase kinase 3; GSK3 alpha; GSK-3 alpha; GSK-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.4 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase UFO (AXL) | Successful Target | ||||
UniProt ID | UFO_HUMAN | |||||
Gene Name | AXL | |||||
Synonyms |
UFO; Tyrosine-protein kinase receptor UFO; AXL oncogene
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3 nM | [7] | ||
Co-Target Name | Fibroblast growth factor receptor 1 (FGFR1) | Successful Target | ||||
UniProt ID | FGFR1_HUMAN | |||||
Gene Name | FGFR1 | |||||
Synonyms |
c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.89 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase B-raf (BRAF) | Successful Target | ||||
UniProt ID | BRAF_HUMAN | |||||
Gene Name | BRAF | |||||
Synonyms |
V-Raf murine sarcoma viral oncogene homolog B1; RAFB1; Proto-oncogene B-Raf; P94; BRAF1; BRAF(V599E); BRAF serine/threonine kinase; B-raf protein; B-Raf
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.5 nM | [12] | ||
Co-Target Name | Insulin receptor (INSR) | Successful Target | ||||
UniProt ID | INSR_HUMAN | |||||
Gene Name | INSR | |||||
Synonyms |
IR; CD220 antigen; CD220
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 8.5 nM | [4] | ||
Co-Target Name | Tyrosine-protein kinase BTK (ATK) | Successful Target | ||||
UniProt ID | BTK_HUMAN | |||||
Gene Name | BTK | |||||
Synonyms |
Bruton's tyrosine kinase; Bruton tyrosine kinase; BPK; B-cell progenitor kinase; B cell progenitor kinase; Agammaglobulinemia tyrosine kinase; Agammaglobulinaemia tyrosine kinase; AGMX1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 13.38 nM | [3] | ||
Co-Target Name | Erbb4 tyrosine kinase receptor (Erbb-4) | Successful Target | ||||
UniProt ID | ERBB4_HUMAN | |||||
Gene Name | ERBB4 | |||||
Synonyms |
Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 28.3 nM | [7] | ||
Co-Target Name | Tyrosine-protein kinase ABL1 (ABL) | Successful Target | ||||
UniProt ID | ABL1_HUMAN | |||||
Gene Name | ABL1 | |||||
Synonyms |
p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 30 nM | [15] | ||
Co-Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | ||||
UniProt ID | ERBB2_HUMAN | |||||
Gene Name | ERBB2 | |||||
Synonyms |
p185erbB2; Tyrosine kinase-type cell surface receptor HER2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; NGL; NEU; Metastatic lymph node gene 19 protein; MLN19; MLN 19; HER2; CD340
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 34 nM | [16] | ||
Co-Target Name | Insulin-like growth factor I receptor (IGF1R) | Successful Target | ||||
UniProt ID | IGF1R_HUMAN | |||||
Gene Name | IGF1R | |||||
Synonyms |
Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 35.03 nM | [17] | ||
Co-Target Name | Proto-oncogene c-Met (MET) | Successful Target | ||||
UniProt ID | MET_HUMAN | |||||
Gene Name | MET | |||||
Synonyms |
Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 69.2 nM | [7] | ||
Co-Target Name | Fusion protein Bcr-Abl (Bcr-Abl) | Successful Target | ||||
UniProt ID | BCR_HUMAN-ABL1_HUMAN | |||||
Gene Name | BCR-ABL1 | |||||
Synonyms |
BCR-ABL fusion protein; BCR-ABL
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 121.8 nM | [18] | ||
Co-Target Name | MAP kinase p38 (MAPK12) | Successful Target | ||||
UniProt ID | MK12_HUMAN | |||||
Gene Name | MAPK12 | |||||
Synonyms |
Stress-activated protein kinase 3; SAPK3; Mitogen-activated proteinkinase p38 gamma; Mitogen-activated proteinkinase 12; MAPK12; Extracellular signal-regulated kinase 6; ERK6; ERK5; ERK-6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 275 nM | [1] | ||
Co-Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | ||||
UniProt ID | CDK2_HUMAN | |||||
Gene Name | CDK2 | |||||
Synonyms |
Sin3 associated polypeptide; SIN3-associated protein; P33 protein kinase; Cell division protein kinase 2; CDKN2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.1 nM | [19] | ||
Co-Target Name | Checkpoint kinase-1 (CHK1) | Clinical trial Target | ||||
UniProt ID | CHK1_HUMAN | |||||
Gene Name | CHEK1 | |||||
Synonyms |
Serine/threonine-protein kinase Chk1; Chk1; Cell cycle checkpoint kinase; CHK1 checkpoint homolog
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 0.1 nM | [4] | ||
Co-Target Name | TYK2 tyrosine kinase (TYK2) | Successful Target | ||||
UniProt ID | TYK2_HUMAN | |||||
Gene Name | TYK2 | |||||
Synonyms |
Non-receptor tyrosine-protein kinase TYK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.205 nM | [1] | ||
Co-Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | ||||
UniProt ID | CDK1_HUMAN | |||||
Gene Name | CDK1 | |||||
Synonyms |
P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.4 nM | [20] | ||
Co-Target Name | Microtubule affinity regulating kinase 3 (MARK3) | Clinical trial Target | ||||
UniProt ID | MARK3_HUMAN | |||||
Gene Name | MARK3 | |||||
Synonyms |
cTAK1; Serine/threonine-protein kinase p78; Ser/Thr protein kinase PAR-1; Protein kinase STK10); Protein kinase STK10; Par-1a; MAP/microtubule affinity-regulating kinase 3; EMK2; EMK-2; ELKL motif kinase 2; Cdc25C-associated protein kinase 1; C-TAK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.438 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase Lyn (JTK8) | Clinical trial Target | ||||
UniProt ID | LYN_HUMAN | |||||
Gene Name | LYN | |||||
Synonyms |
p56Lyn; p53Lyn; V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; Lck/Yes-related novel protein tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.473 nM | [3] | ||
Co-Target Name | Maternal embryonic leucine zipper kinase (MELK) | Clinical trial Target | ||||
UniProt ID | MELK_HUMAN | |||||
Gene Name | MELK | |||||
Synonyms |
Protein kinase PK38; Protein kinase Eg3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.542 nM | [1] | ||
Co-Target Name | Ribosomal protein S6 kinase beta-1 (S6K1) | Clinical trial Target | ||||
UniProt ID | KS6B1_HUMAN | |||||
Gene Name | RPS6KB1 | |||||
Synonyms |
p70-S6K 1; p70 ribosomal S6 kinase alpha; p70 S6KA; p70 S6K-alpha; p70 S6 kinase alpha; Serine/threonine-protein kinase 14A; STK14A; S6K-beta-1; S6K; Ribosomal protein S6 kinase I; P70S6K1; P70-S6K; 70 kDa ribosomal protein S6 kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.553 nM | [1] | ||
Co-Target Name | Aurora kinase A (AURKA) | Clinical trial Target | ||||
UniProt ID | AURKA_HUMAN | |||||
Gene Name | AURKA | |||||
Synonyms |
hARK1; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; STK6; STK15; IAK1; Breast tumor-amplified kinase; BTAK; Aurora/IPL1-related kinase 1; Aurora-related kinase 1; Aurora-A; Aurora 2; AYK1; AURA; ARK1; ARK-1; AIRK1; AIK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.6 nM | [9] | ||
Co-Target Name | RAC-gamma serine/threonine-protein kinase (AKT3) | Clinical trial Target | ||||
UniProt ID | AKT3_HUMAN | |||||
Gene Name | AKT3 | |||||
Synonyms |
STK-2; RAC-PK-gamma; Protein kinase B gamma; Protein kinase Akt-3; PKBG; PKB gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.64 nM | [21] | ||
Co-Target Name | Apoptosis signal-regulating kinase 1 (MAP3K5) | Clinical trial Target | ||||
UniProt ID | M3K5_HUMAN | |||||
Gene Name | MAP3K5 | |||||
Synonyms |
Mitogen-activated protein kinase kinase kinase 5; MEKK5; MEKK 5; MEK kinase 5; MAPKKK5; MAPK/ERK kinase kinase 5; ASK1; ASK-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.69 nM | [22] | ||
Co-Target Name | Glucokinase (GCK) | Clinical trial Target | ||||
UniProt ID | HXK4_HUMAN | |||||
Gene Name | GCK | |||||
Synonyms |
Hexokinase type IV; Hexokinase D; HK4; HK IV
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.81 nM | [1] | ||
Co-Target Name | Vascular endothelial growth factor receptor 3 (FLT-4) | Clinical trial Target | ||||
UniProt ID | VGFR3_HUMAN | |||||
Gene Name | FLT4 | |||||
Synonyms |
VEGFR3; VEGFR-3; VEGF-3 receptor; Tyrosine-protein kinase receptor FLT4; Fms-like tyrosine kinase 4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.9 nM | [7] | ||
Co-Target Name | Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | Clinical trial Target | ||||
UniProt ID | IKKB_HUMAN | |||||
Gene Name | IKBKB | |||||
Synonyms |
Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Inhibitor of nuclear factor kappa-B kinase subunit beta; IkBKB; IKKB; IKK2; IKK-beta; IKK-B; I-kappa-B-kinase beta; I-kappa-B kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.9 nM | [23] | ||
Co-Target Name | Polo-like kinase 1 (PLK1) | Clinical trial Target | ||||
UniProt ID | PLK1_HUMAN | |||||
Gene Name | PLK1 | |||||
Synonyms |
Serine/threonine-protein kinase PLK1; Serine/threonine-protein kinase 13; Serine-threonine protein kinase 13; STPK13; Plk1; PLK-1; PLK; Mitoticserine-threonine kinase polo-like kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.92 ug.mL-1 | [24] | ||
Co-Target Name | Rho-associated protein kinase 2 (ROCK2) | Successful Target | ||||
UniProt ID | ROCK2_HUMAN | |||||
Gene Name | ROCK2 | |||||
Synonyms |
p164 ROCK-2; Rho-associated, coiled-coil-containing protein kinase II; Rho-associated, coiled-coil-containing protein kinase 2; Rho kinase 2; ROCK-II; KIAA0619
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.933 nM | [1] | ||
Co-Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | ||||
UniProt ID | MK01_HUMAN | |||||
Gene Name | MAPK1 | |||||
Synonyms |
PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 1 nM | [25] | ||
Co-Target Name | Aurora kinase B (AURKB) | Clinical trial Target | ||||
UniProt ID | AURKB_HUMAN | |||||
Gene Name | AURKB | |||||
Synonyms |
Serine/threonine-protein kinase aurora-B; Serine/threonine-protein kinase 5; Serine/threonine-protein kinase 12; Serine/threonine protein kinase 12; STK5; STK12; Aurora/IPL1-related kinase 2; Aurora-related kinase 2; Aurora-B; Aurora-2 kinase; Aurora-2; Aurora- and Ipl1-like midbody-associated protein 1; Aurora 1; ARK2; ARK-2; AIRK2; AIM1; AIM-1; AIK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1 nM | [26] | ||
Co-Target Name | Leucine-rich repeat kinase 2 (LRRK2) | Clinical trial Target | ||||
UniProt ID | LRRK2_HUMAN | |||||
Gene Name | LRRK2 | |||||
Synonyms |
PARK8; Leucine-rich repeat serine/threonine-protein kinase 2; Dardarin
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1 nM | [27] | ||
Co-Target Name | Macrophage colony-stimulating factor 1 receptor (CSF1R) | Clinical trial Target | ||||
UniProt ID | CSF1R_HUMAN | |||||
Gene Name | CSF1R | |||||
Synonyms |
Proto-oncogene c-Fms; M-CSF-R; FMS; CSF-1R; CSF-1-R; CSF-1 receptor; CD115
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.14 nM | [12] | ||
Co-Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Clinical trial Target | ||||
UniProt ID | AKT1_HUMAN | |||||
Gene Name | AKT1 | |||||
Synonyms |
RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; PKB alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.5 nM | [20] | ||
Co-Target Name | Mixed lineage kinase 1 (MAP3K9) | Clinical trial Target | ||||
UniProt ID | M3K9_HUMAN | |||||
Gene Name | MAP3K9 | |||||
Synonyms |
PRKE1; Mitogen-activated protein kinase kinase kinase 9; MLK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.52 nM | [1] | ||
Co-Target Name | PAK-4 protein kinase (PAK4) | Clinical trial Target | ||||
UniProt ID | PAK4_HUMAN | |||||
Gene Name | PAK4 | |||||
Synonyms |
p21-activated kinase 4; Serine/threonine-protein kinase PAK 4; PAK-4; KIAA1142
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.9 nM | [28] | ||
Co-Target Name | CaM-kinase II (CAMK2) | Clinical trial Target | ||||
UniProt ID | KCC2A_HUMAN; KCC2B_HUMAN; KCC2D_HUMAN; KCC2G_HUMAN | |||||
Gene Name | CAMK2A; CAMK2B; CAMK2D; CAMK2G | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type II; CaMK-II; CaM kinase II; CAMK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2 nM | [29] | ||
Co-Target Name | Yes tyrosine kinase (YES) | Clinical trial Target | ||||
UniProt ID | YES_HUMAN | |||||
Gene Name | YES1 | |||||
Synonyms |
p61-Yes; Yes p59-Fyn; Yes Protooncogene Syn; Tyrosine-protein kinase Yes; Proto-oncogene c-Yes
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.35 nM | [30] | ||
Co-Target Name | Aurora kinase C (AURKC) | Clinical trial Target | ||||
UniProt ID | AURKC_HUMAN | |||||
Gene Name | AURKC | |||||
Synonyms |
Serine/threonine-protein kinase aurora-C; STK13; Aurora/Ipl1/Eg2 protein 2; Aurora/Ipl1-related kinase 3; Aurora-related kinase 3; Aurora-C; Aurora 3; ARK3; ARK-3; AIRK3; AIK3; AIE2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.42 nM | [1] | ||
Co-Target Name | ERK activator kinase 1 (MEK1) | Clinical trial Target | ||||
UniProt ID | MP2K1_HUMAN | |||||
Gene Name | MAP2K1 | |||||
Synonyms |
PRKMK1; Mitogen-activated protein kinase kinase 1; MKK1; MEK 1; MAPKK 1; MAPK/ERKkinase 1; MAPK/ERK kinase 1; MAP kinase kinase 1; Dual specificity mitogen-activated protein kinase kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.5 nM | Click to Show More | [31] | |
2 | Staurosporine | Drug Info | IC50 = 2.5 nM | [31] | ||
Co-Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | ||||
UniProt ID | GSK3B_HUMAN | |||||
Gene Name | GSK3B | |||||
Synonyms |
Serine/threonine-protein kinase GSK3B; GSK-3 beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.62 nM | [12] | ||
Co-Target Name | Serine/threonine-protein kinase pim-1 (PIM1) | Clinical trial Target | ||||
UniProt ID | PIM1_HUMAN | |||||
Gene Name | PIM1 | |||||
Synonyms |
Pim-1 proto-oncogene, serine/threonine kinase; PIM
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.67 nM | [3] | ||
Co-Target Name | Positive transcription elongation factor b (P-TEFb) | Clinical trial Target | ||||
UniProt ID | CDK9_HUMAN-CCNT1_HUMAN | |||||
Gene Name | CDK9-CCNT1 | |||||
Synonyms |
P-TEFb
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.3 nM | [21] | ||
Co-Target Name | Serine/threonine-protein kinase Chk2 (RAD53) | Clinical trial Target | ||||
UniProt ID | CHK2_HUMAN | |||||
Gene Name | CHEK2 | |||||
Synonyms |
hCds1; Hucds1; Checkpoint kinase 2; Cds1 homolog; Cds1; CHK2 checkpoint homolog; CHK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.34 nM | [9] | ||
Co-Target Name | Renal carcinoma antigen NY-REN-64 (IRAK-4) | Clinical trial Target | ||||
UniProt ID | IRAK4_HUMAN | |||||
Gene Name | IRAK4 | |||||
Synonyms |
Interleukin-1 receptor-associated kinase 4; IRAK-4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.21 nM | [1] | ||
Co-Target Name | Phosphoinositide dependent protein kinase-1 (PDPK1) | Clinical trial Target | ||||
UniProt ID | PDPK1_HUMAN | |||||
Gene Name | PDPK1 | |||||
Synonyms |
PDK1; HPDK1; 3-phosphoinositide-dependent protein kinase 1; 3-Phosphoinositide-dependent kinase-1; 3'-phosphoinositide dependent kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.2 nM | [32] | ||
Co-Target Name | Vascular endothelial growth factor receptor 1 (FLT-1) | Clinical trial Target | ||||
UniProt ID | VGFR1_HUMAN | |||||
Gene Name | FLT1 | |||||
Synonyms |
Vascular permeability factor receptor; VEGFR1; VEGFR-1; VEGF-1 receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1; FRT; FLT
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.4 nM | [7] | ||
Co-Target Name | Serine/threonine-protein kinase Sgk1 (SGK1) | Clinical trial Target | ||||
UniProt ID | SGK1_HUMAN | |||||
Gene Name | SGK1 | |||||
Synonyms |
Serum/glucocorticoid-regulated kinase 1; SGK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.75 nM | [1] | ||
Co-Target Name | Cyclin-dependent kinase 3 (CDK3) | Clinical trial Target | ||||
UniProt ID | CDK3_HUMAN | |||||
Gene Name | CDK3 | |||||
Synonyms |
Cyclindependent kinase 3; Cell division protein kinase 3; CDKN3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.9 nM | [21] | ||
Co-Target Name | Serine/threonine-protein kinase pim-2 (PIM2) | Clinical trial Target | ||||
UniProt ID | PIM2_HUMAN | |||||
Gene Name | PIM2 | |||||
Synonyms |
Pim-2h; PIM2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 7 nM | [33] | ||
Co-Target Name | Fibroblast growth factor receptor 3 (FGFR3) | Clinical trial Target | ||||
UniProt ID | FGFR3_HUMAN | |||||
Gene Name | FGFR3 | |||||
Synonyms |
JTK4; FGFR-3; CD333
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 9.25 nM | [3] | ||
Co-Target Name | T-cell-specific kinase (ITK) | Clinical trial Target | ||||
UniProt ID | ITK_HUMAN | |||||
Gene Name | ITK | |||||
Synonyms |
Tyrosine kinase ITK; Inducible T cell kinase; EMT
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10 nM | [1] | ||
Co-Target Name | Myosin light kinase (MYLK) | Clinical trial Target | ||||
UniProt ID | MYLK_HUMAN | |||||
Gene Name | MYLK | |||||
Synonyms |
smMLCK; Telokin; Myosin light chain kinase, smooth muscle; MYLK1; MLCK210; MLCK1; MLCK; Kinase-related protein; KRP; Endothelial cell (EC) MLCK isoform; EC mlck; 210,000 molecular weight myosin light chain kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10 nM | [34] | ||
Co-Target Name | Stress-activated protein kinase 2a (p38 alpha) | Clinical trial Target | ||||
UniProt ID | MK14_HUMAN | |||||
Gene Name | MAPK14 | |||||
Synonyms |
SAPK2A; P38 mitogen activatedprotein kinase; P38 Mitogen-activatedprotein kinase alpha; Mitogen-activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; MXI2; MAX-interacting protein 2; MAPK 14; MAP kinase p38alpha; MAP kinase p38 alpha; MAP kinase MXI2; MAP kinase 14; Cytokine suppressive anti-inflammatory drug-binding protein; Cytokine suppressive anti-inflammatory drug binding protein; CSPB1; CSBP2; CSBP1; CSBP; CSAID-binding protein; CSAID binding protein; CRK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10.5 nM | [7] | ||
Co-Target Name | Erbb3 tyrosine kinase receptor (Erbb-3) | Clinical trial Target | ||||
UniProt ID | ERBB3_HUMAN | |||||
Gene Name | ERBB3 | |||||
Synonyms |
Tyrosine kinase-type cell surface receptor HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; HER3; C-erbB3; C-erbB-3 protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10.6 nM | [7] | ||
Co-Target Name | Aldosterone synthase (CYP11B2) | Clinical trial Target | ||||
UniProt ID | C11B2_HUMAN | |||||
Gene Name | CYP11B2 | |||||
Synonyms |
Steroid 18hydroxylase; Cytochrome P450C18; Cytochrome P450Aldo; Cytochrome P450 11B2, mitochondrial; CYPXIB2; CYP11B2; Aldosteronesynthesizing enzyme; ALDOS
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11 nM | [35] | ||
Co-Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | ||||
UniProt ID | FAK1_HUMAN | |||||
Gene Name | PTK2 | |||||
Synonyms |
pp125FAK; p125FAK; Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Focal adhesion kinase-related nonkinase; FRNK; FAK1; FADK 1; FADK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11 nM | [36] | ||
Co-Target Name | Tyrosine-protein kinase Mer (MERTK) | Clinical trial Target | ||||
UniProt ID | MERTK_HUMAN | |||||
Gene Name | MERTK | |||||
Synonyms |
Receptor tyrosine kinase MerTK; Proto-oncogene c-Mer
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11.6 nM | [1] | ||
Co-Target Name | Protein kinase N3 (PKN3) | Clinical trial Target | ||||
UniProt ID | PKN3_HUMAN | |||||
Gene Name | PKN3 | |||||
Synonyms |
Serine/threonine-protein kinase N3; Protein-kinase C-related kinase 3; Protein kinase PKN-beta; PKNBETA
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 13.2 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 3 (EPHA3) | Clinical trial Target | ||||
UniProt ID | EPHA3_HUMAN | |||||
Gene Name | EPHA3 | |||||
Synonyms |
hEK4; Tyrosineprotein kinase receptor ETK1; Tyrosineprotein kinase TYRO4; Tyrosine-protein kinase receptor ETK1; Tyrosine-protein kinase TYRO4; TYRO4; Human embryo kinase; HEK; Ephrin typeA receptor 3; Ephlike tyrosine kinase 1; Eph-like tyrosine kinase 1; ETK1; ETK protein; EPHlike kinase 4; EPH-like kinase 4; EK4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 19.72 nM | [3] | ||
Co-Target Name | MAP kinase signal-integrating kinase 2 (MKNK2) | Clinical trial Target | ||||
UniProt ID | MKNK2_HUMAN | |||||
Gene Name | MKNK2 | |||||
Synonyms |
Mnk2; MAPK signal-integrating kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 20.3 nM | [1] | ||
Co-Target Name | MAPK-activated protein kinase 2 (MAPKAPK2) | Clinical trial Target | ||||
UniProt ID | MAPK2_HUMAN | |||||
Gene Name | MAPKAPK2 | |||||
Synonyms |
MK2; MK-2; MAPKactivated protein kinase 2; MAPKAPK-2; MAPKAP-K2; MAPKAP kinase 2; MAP kinaseactivated protein kinase 2; MAP kinase-activated protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 36.25 nM | [17] | ||
Co-Target Name | ERK activator kinase 2 (MEK2) | Clinical trial Target | ||||
UniProt ID | MP2K2_HUMAN | |||||
Gene Name | MAP2K2 | |||||
Synonyms |
PRKMK2; MKK2; MEK 2; MAPKK 2; MAPK/ERK kinase 2; MAP kinase kinase 2; Dual specificity mitogenactivated protein kinase kinase 2; Dual specificity mitogen-activated protein kinase kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 37.4 nM | [1] | ||
Co-Target Name | MAPK/ERK kinase kinase 2 (MAP3K2) | Clinical trial Target | ||||
UniProt ID | M3K2_HUMAN | |||||
Gene Name | MAP3K2 | |||||
Synonyms |
Mitogen-activated protein kinase kinase kinase 2; MEKK2; MEKK 2; MEK kinase 2; MAPKKK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 43.5 nM | [1] | ||
Co-Target Name | Angiopoietin 1 receptor (TEK) | Clinical trial Target | ||||
UniProt ID | TIE2_HUMAN | |||||
Gene Name | TEK | |||||
Synonyms |
hTIE2; VMCM1; VMCM; Tyrosine-protein kinase receptor TIE-2; Tyrosine-protein kinase receptor TEK; Tyrosine kinase with Ig and EGF homology domains-2; Tunica interna endothelial cell kinase; TIE2; P140 TEK; Endothelial tyrosine kinase; Endothelial Cell-Specific Receptor TIE-2; CD202b antigen; CD202b
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 50.9 nM | [3] | ||
Co-Target Name | MAPK signal-integrating kinase 1 (MKNK1) | Clinical trial Target | ||||
UniProt ID | MKNK1_HUMAN | |||||
Gene Name | MKNK1 | |||||
Synonyms |
Mnk1; MAP kinase signal-integrating kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 52.7 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 2 (EPHA2) | Clinical trial Target | ||||
UniProt ID | EPHA2_HUMAN | |||||
Gene Name | EPHA2 | |||||
Synonyms |
Tyrosine-protein kinase receptor ECK; Epithelial cell kinase; EphA2receptor; ECK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 74.5 nM | [1] | ||
Co-Target Name | Macrophage-stimulating protein receptor (RON) | Clinical trial Target | ||||
UniProt ID | RON_HUMAN | |||||
Gene Name | MST1R | |||||
Synonyms |
p185Ron; Proteintyrosine kinase 8; Macrophagestimulating protein receptor beta chain; Macrophagestimulating protein receptor; MST1R; MSP receptor; CDw136; CD136
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 102.7 nM | [7] | ||
Co-Target Name | Fibroblast growth factor receptor 4 (FGFR4) | Clinical trial Target | ||||
UniProt ID | FGFR4_HUMAN | |||||
Gene Name | FGFR4 | |||||
Synonyms |
TKF; JTK2; FGFR-4; CD334
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 107 nM | [1] | ||
Co-Target Name | Ephrin type-B receptor 2 (EPHB2) | Clinical trial Target | ||||
UniProt ID | EPHB2_HUMAN | |||||
Gene Name | EPHB2 | |||||
Synonyms |
hEK5; Tyrosine-protein kinase receptor EPH-3; Tyrosine-protein kinase TYRO5; TYRO5; Renal carcinoma antigen NY-REN-47; Receptor protein-tyrosine kinase HEK5; EphB2 receptor tyrosine kinase; EphB2; EPTH3; EPHT3; EPH-like kinase 5; EPH tyrosine kinase 3; ELK-related tyrosine kinase; EK5; Developmentally-regulated Eph-related tyrosine kinase; DRT
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 116 nM | [1] | ||
Co-Target Name | Ephrin type-B receptor 4 (EPHB4) | Clinical trial Target | ||||
UniProt ID | EPHB4_HUMAN | |||||
Gene Name | EPHB4 | |||||
Synonyms |
Tyrosine-protein kinase TYRO11; TYRO11; MYK1; Hepatoma transmembrane kinase; HTK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 126.4 nM | [3] | ||
Co-Target Name | Proto-oncogene c-RAF (c-RAF) | Clinical trial Target | ||||
UniProt ID | RAF1_HUMAN | |||||
Gene Name | RAF1 | |||||
Synonyms |
cRaf; Raf-1; RAF proto-oncogene serine/threonine-protein kinase; RAF
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 130 nM | [37] | ||
Co-Target Name | Tyrosine-protein kinase BRK (PTK6) | Clinical trial Target | ||||
UniProt ID | PTK6_HUMAN | |||||
Gene Name | PTK6 | |||||
Synonyms |
Protein-tyrosine kinase 6; Breast tumor kinase; BRK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 247 nM | [7] | ||
Co-Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | ||||
UniProt ID | MK08_HUMAN | |||||
Gene Name | MAPK8 | |||||
Synonyms |
Stress-activated protein kinase 1c; SAPK1c; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 361 nM | [1] | ||
Co-Target Name | Fibroblast growth factor receptor (FGFR) | Clinical trial Target | ||||
UniProt ID | FGFR1_HUMAN; FGFR2_HUMAN; FGFR3_HUMAN; FGFR4_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
FGF receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 420 nM | [25] | ||
Co-Target Name | MAPK/ERK kinase kinase 1 (MAP3K1) | Clinical trial Target | ||||
UniProt ID | M3K1_HUMAN | |||||
Gene Name | MAP3K1 | |||||
Synonyms |
Mitogenactivated protein kinase kinase kinase 1; Mitogen-activated protein kinase kinase kinase 1; MEKK1; MEKK 1; MEKK; MEK kinase 1; MAPKKK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 485 nM | [1] | ||
Co-Target Name | Activin receptor-like kinase-1 (ACVRL1) | Clinical trial Target | ||||
UniProt ID | ACVL1_HUMAN | |||||
Gene Name | ACVRL1 | |||||
Synonyms |
Serine/threonine-protein kinase receptor R3; SKR3; Activin receptor-like kinase 1; ALK-1; ACVRLK1; ACVRL1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 850 nM | [38] | ||
Co-Target Name | Stress-activated protein kinase (p38) | Clinical trial Target | ||||
UniProt ID | MK11_HUMAN; MK12_HUMAN; MK13_HUMAN; MK14_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
p38) Stress-activated protein kinase; P38 MAPK; P38 MAP kinase; Mitogen-activated protein kinase p38
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 1000 nM | [25] | ||
Co-Target Name | PIM-3 protein kinase (PIM3) | Patented-recorded Target | ||||
UniProt ID | PIM3_HUMAN | |||||
Gene Name | PIM3 | |||||
Synonyms |
Serine/threonine-protein kinase pim-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.0885 nM | [1] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha-1 (RSK1) | Patented-recorded Target | ||||
UniProt ID | KS6A1_HUMAN | |||||
Gene Name | RPS6KA1 | |||||
Synonyms |
p90S6K; p90RSK1; p90-RSK 1; S6K-alpha-1; Ribosomal S6 kinase 1; RSK-1; MAPKAPK1A; MAPKAPK-1a; MAPKAP kinase 1a; MAPK-activated protein kinase 1a; MAP kinase-activated protein kinase 1a; 90 kDa ribosomal protein S6 kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.09 nM | [3] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha-3 (RSK3) | Patented-recorded Target | ||||
UniProt ID | KS6A3_HUMAN | |||||
Gene Name | RPS6KA3 | |||||
Synonyms |
pp90RSK2; p90RSK3; p90-RSK 3; S6K-alpha-3; Ribosomal S6 kinase 2; RSK2; RSK-2; MAPKAPK1B; MAPKAPK-1b; MAPKAP kinase 1b; MAPK-activated protein kinase 1b; MAP kinase-activated protein kinase 1b; Insulin-stimulated protein kinase 1; ISPK1; ISPK-1; 90 kDa ribosomal protein S6 kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.124 nM | [1] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha-6 (RSK6) | Patented-recorded Target | ||||
UniProt ID | KS6A6_HUMAN | |||||
Gene Name | RPS6KA6 | |||||
Synonyms |
pp90RSK4; p90RSK6; p90-RSK 6; S6K-alpha-6; Ribosomal S6 kinase 4; RSK4; RSK-4; 90 kDa ribosomal protein S6 kinase 6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.159 nM | [1] | ||
Co-Target Name | Pyruvate dehydrogenase kinase 1 (PDHK1) | Patented-recorded Target | ||||
UniProt ID | PDK1_HUMAN | |||||
Gene Name | PDK1 | |||||
Synonyms |
Pyruvate dehydrogenase kinase isoform 1; Pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 1, mitochondrial; PDHK1; PDH kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.506 nM | [1] | ||
Co-Target Name | MEK kinase kinase 4 (MAP4K4) | Patented-recorded Target | ||||
UniProt ID | M4K4_HUMAN | |||||
Gene Name | MAP4K4 | |||||
Synonyms |
Nckinteracting kinase; Nck-interacting kinase; Mitogenactivated protein kinase kinase kinase kinase 4; Mitogen-activated protein kinase kinase kinase kinase 4; MEKKK 4; MAPK/ERK kinase kinase kinase 4; KIAA0687; HPK/GCKlike kinase HGK; HPK/GCK-like kinase HGK; HGK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.57 nM | [1] | ||
Co-Target Name | Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B) | Patented-recorded Target | ||||
UniProt ID | DYR1B_HUMAN | |||||
Gene Name | DYRK1B | |||||
Synonyms |
Minibrain-related kinase; MIRK; Dual specificity tyrosine-phosphorylation-regulated kinase 1B
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.967 nM | [1] | ||
Co-Target Name | B lymphocyte kinase (BLK) | Patented-recorded Target | ||||
UniProt ID | BLK_HUMAN | |||||
Gene Name | BLK | |||||
Synonyms |
p55-Blk; Tyrosine-protein kinase Blk
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.07 nM | [1] | ||
Co-Target Name | Discoidin domain-containing receptor 2 (DDR2) | Patented-recorded Target | ||||
UniProt ID | DDR2_HUMAN | |||||
Gene Name | DDR2 | |||||
Synonyms |
Tyrosine-protein kinase TYRO10; Receptor protein-tyrosine kinase TKT; Neurotrophic tyrosine kinase, receptor-related 3; Discoidin domain-containing receptor tyrosine kinase 2; Discoidin domain receptor 2; DDR2; CD167 antigen-like family member B
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.19 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase ZAP-70 (ZAP-70) | Patented-recorded Target | ||||
UniProt ID | ZAP70_HUMAN | |||||
Gene Name | ZAP70 | |||||
Synonyms |
Syk-related tyrosine kinase; SRK; 70 kDa zeta-chain associated protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.3 nM | [36] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha-5 (RSK5) | Patented-recorded Target | ||||
UniProt ID | KS6A5_HUMAN | |||||
Gene Name | RPS6KA5 | |||||
Synonyms |
S6K-alpha-5; RSKL; RSK-like protein kinase; Nuclear mitogen- and stress-activated protein kinase 1; MSK1; 90 kDa ribosomal protein S6 kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.4 nM | [32] | ||
Co-Target Name | Hematopoietic cell kinase (HCK) | Patented-recorded Target | ||||
UniProt ID | HCK_HUMAN | |||||
Gene Name | HCK | |||||
Synonyms |
p61Hck; p59Hck; p59-HCK/p60-HCK; Tyrosine-protein kinase HCK; Hemopoietic cell kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.9 nM | [1] | ||
Co-Target Name | NF-kappa-B-activating kinase (TBK1) | Patented-recorded Target | ||||
UniProt ID | TBK1_HUMAN | |||||
Gene Name | TBK1 | |||||
Synonyms |
TANK-binding kinase 1; T2K; Serine/threonine-protein kinase TBK1; NAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.18 nM | [1] | ||
Co-Target Name | TYRO3 tyrosine kinase receptor (TYRO3) | Patented-recorded Target | ||||
UniProt ID | TYRO3_HUMAN | |||||
Gene Name | TYRO3 | |||||
Synonyms |
Tyrosine-protein kinase receptor TYRO3; Tyrosine-protein kinase TIF; Tyrosine-protein kinase SKY; Tyrosine-protein kinase RSE; Tyrosine-protein kinase DTK; Tyrosine-protein kinase BYK; TIF; SKY; RSE; DTK; BYK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.75 nM | [1] | ||
Co-Target Name | Epithelial discoidin domain receptor 1 (DDR1) | Patented-recorded Target | ||||
UniProt ID | DDR1_HUMAN | |||||
Gene Name | DDR1 | |||||
Synonyms |
Tyrosine-protein kinase CAK; Tyrosine kinase DDR; TRKE; TRK E; RTK6; Protein-tyrosine kinase RTK-6; Protein-tyrosine kinase 3A; PTK3A; NTRK4; NEP; Mammary carcinoma kinase 10; MCK-10; HGK2; Epithelial discoidin domain-containing receptor 1; EDDR1; Discoidin receptor tyrosine kinase; Cell adhesion kinase; CD167a; CD167 antigen-like family member A
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.28 nM | [1] | ||
Co-Target Name | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Patented-recorded Target | ||||
UniProt ID | DYR1A_HUMAN | |||||
Gene Name | DYRK1A | |||||
Synonyms |
hMNB; Protein kinase minibrain homolog; MNBH; MNB; HP86; Dual specificity tyrosine-phosphorylation-regulated kinase 1A; Dual specificity YAK1-related kinase; DYRK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.93 nM | [1] | ||
Co-Target Name | CDC-like kinase 2 (CLK2) | Patented-recorded Target | ||||
UniProt ID | CLK2_HUMAN | |||||
Gene Name | CLK2 | |||||
Synonyms |
Dual specificity protein kinase CLK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.52 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase BMX (BMX) | Patented-recorded Target | ||||
UniProt ID | BMX_HUMAN | |||||
Gene Name | BMX | |||||
Synonyms |
NTK38; Epithelial and endothelial tyrosine kinase; ETK; Cytoplasmic tyrosine-protein kinase BMX; Bone marrow tyrosine kinase gene in chromosome X protein
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.16 nM | [1] | ||
Co-Target Name | CDC-like kinase 1 (CLK1) | Patented-recorded Target | ||||
UniProt ID | CLK1_HUMAN | |||||
Gene Name | CLK1 | |||||
Synonyms |
Dual specificity protein kinase CLK1; CLK; CDClike kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 14.2 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase CSK (CSK) | Patented-recorded Target | ||||
UniProt ID | CSK_HUMAN | |||||
Gene Name | CSK | |||||
Synonyms |
Protein-tyrosine kinase CYL; C-Src kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 14.3 nM | [1] | ||
Co-Target Name | SPS1/STE20-related protein kinase YSK4 (YSK4) | Patented-recorded Target | ||||
UniProt ID | M3K19_HUMAN | |||||
Gene Name | MAP3K19 | |||||
Synonyms |
Regulated in COPD, protein kinase; RCK; Mitogen-activated protein kinase kinase kinase 19
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 15.6 nM | [1] | ||
Co-Target Name | SRSF protein kinase 1 (SRPK1) | Patented-recorded Target | ||||
UniProt ID | SRPK1_HUMAN | |||||
Gene Name | SRPK1 | |||||
Synonyms |
Serine/arginine-rich protein-specific kinase 1; SR-protein-specific kinase 1; SFRS protein kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 24.5 nM | [1] | ||
Co-Target Name | Calmodulin-dependent kinase II (CAMKK2) | Patented-recorded Target | ||||
UniProt ID | KKCC2_HUMAN | |||||
Gene Name | CAMKK2 | |||||
Synonyms |
KIAA0787; Calcium/calmodulin-dependent protein kinase kinase beta; Calcium/calmodulin-dependent protein kinase kinase 2; CaMKK beta; CaMKK 2; CaM-kinase kinase beta; CaM-kinase kinase 2; CaM-KK beta; CaM-KK 2; CAMKKB
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 33.6 nM | [1] | ||
Co-Target Name | Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3) | Patented-recorded Target | ||||
UniProt ID | DYRK3_HUMAN | |||||
Gene Name | DYRK3 | |||||
Synonyms |
Regulatory erythroid kinase; REDK; Dual specificity tyrosine-phosphorylation-regulated kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 34.8 nM | [1] | ||
Co-Target Name | Activated CDC42 kinase 1 (ACK-1) | Patented-recorded Target | ||||
UniProt ID | ACK1_HUMAN | |||||
Gene Name | TNK2 | |||||
Synonyms |
Tyrosine kinase non-receptor protein 2; ACK1; ACK-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 34.8 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase Tec (PSCTK4) | Patented-recorded Target | ||||
UniProt ID | TEC_HUMAN | |||||
Gene Name | TEC | |||||
Synonyms |
Tec protein tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 43.1 nM | [1] | ||
Co-Target Name | IL-1 receptor-associated kinase 1 (IRAK1) | Patented-recorded Target | ||||
UniProt ID | IRAK1_HUMAN | |||||
Gene Name | IRAK1 | |||||
Synonyms |
Interleukin-1 receptor-associated kinase 1; IRAK-1; IRAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 59.3 nM | [1] | ||
Co-Target Name | G protein-coupled receptor kinase 5 (GRK5) | Patented-recorded Target | ||||
UniProt ID | GRK5_HUMAN | |||||
Gene Name | GRK5 | |||||
Synonyms |
GPRK5; G protein-coupled receptor kinase GRK5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 73.3 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase EIF2AK2 (p68) | Patented-recorded Target | ||||
UniProt ID | E2AK2_HUMAN | |||||
Gene Name | EIF2AK2 | |||||
Synonyms |
p68 kinase; Proteinkinase RNA-activated; Interferon-inducible RNA-dependent protein kinase p68; Interferon-induced, double-stranded RNA-activated protein kinase p68
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 100 nM | [39] | ||
Co-Target Name | Extracellular signal-regulated kinase 5 (ERK5) | Patented-recorded Target | ||||
UniProt ID | MK07_HUMAN | |||||
Gene Name | MAPK7 | |||||
Synonyms |
PRKM7; Mitogen-activated protein kinase 7; MAPK 7; MAP kinase 7; ERK-5; Big MAP kinase 1; BMK1; BMK-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 121.6 nM | [3] | ||
Co-Target Name | Polo-like kinase 2 (PLK2) | Patented-recorded Target | ||||
UniProt ID | PLK2_HUMAN | |||||
Gene Name | PLK2 | |||||
Synonyms |
hSNK; hPlk2; Serum-inducible kinase; Serine/threonine-protein kinase SNK; Serine/threonine-protein kinase PLK2; SNK; PLK-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 197 nM | [4] | ||
Co-Target Name | Endoplasmic reticulum to nucleus signaling 1 (ERN1) | Patented-recorded Target | ||||
UniProt ID | ERN1_HUMAN | |||||
Gene Name | ERN1 | |||||
Synonyms |
Serine/threonine-protein kinase/endoribonuclease IRE1; Ire1-alpha; IRE1a; IRE1; Inositol-requiring protein 1; hIRE1p; Endoplasmic reticulum-to-nucleus signaling 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 204 nM | [1] | ||
Co-Target Name | Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2) | Patented-recorded Target | ||||
UniProt ID | DYRK2_HUMAN | |||||
Gene Name | DYRK2 | |||||
Synonyms |
Dual specificity tyrosine-phosphorylation-regulated kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 248 nM | [1] | ||
Co-Target Name | Casein kinase II alpha prime (CSNK2A2) | Patented-recorded Target | ||||
UniProt ID | CSK22_HUMAN | |||||
Gene Name | CSNK2A2 | |||||
Synonyms |
Casein kinase II subunit alpha'; CK2A2; CK II alpha'
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 844 nM | [1] | ||
Co-Target Name | MAPK-activated protein kinase 5 (MAPKAPK5) | Discontinued Target | ||||
UniProt ID | MAPK5_HUMAN | |||||
Gene Name | MAPKAPK5 | |||||
Synonyms |
p38regulated/activated protein kinase; p38-regulated/activated protein kinase; PRAK; MK5; MK-5; MAPKactivated protein kinase 5; MAPKAPK-5; MAPKAP-K5; MAPKAP kinase 5; MAP kinaseactivated protein kinase 5; MAP kinase-activated protein kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 295 nM | [1] | ||
Co-Target Name | MEK kinase kinase 3 (MAP4K3) | Literature-reported Target | ||||
UniProt ID | M4K3_HUMAN | |||||
Gene Name | MAP4K3 | |||||
Synonyms |
RAB8IPL1; Mitogen-activated protein kinase kinase kinase kinase 3; MEKKK 3; MAPK/ERK kinase kinase kinase 3; Germinal center kinase-related protein kinase; GLK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.0825 nM | [1] | ||
Co-Target Name | Phosphorylase kinase testis gamma 2 (PHKG2) | Literature-reported Target | ||||
UniProt ID | PHKG2_HUMAN | |||||
Gene Name | PHKG2 | |||||
Synonyms |
Phosphorylase kinase subunit gamma-2; Phosphorylase b kinase gamma catalytic chain, liver/testis isoform; PSK-C3; PHK-gamma-T; PHK-gamma-LT
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 0.1 nM | [4] | ||
Co-Target Name | HUMAN microtubule affinity regulating kinase 2 (MARK2) | Literature-reported Target | ||||
UniProt ID | MARK2_HUMAN | |||||
Gene Name | MARK2 | |||||
Synonyms |
Par-1b; Par1b; PAR1 homolog b; PAR1 homolog; MAP/microtubule affinity-regulating kinase 2; EMK-1; ELKL motif kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.133 nM | [1] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha-2 (RSK2) | Literature-reported Target | ||||
UniProt ID | KS6A2_HUMAN | |||||
Gene Name | RPS6KA2 | |||||
Synonyms |
pp90RSK3; p90RSK2; p90-RSK 2; S6K-alpha-2; Ribosomal S6 kinase 3; RSK3; RSK-3; MAPKAPK1C; MAPKAPK-1c; MAPKAP kinase 1c; MAPK-activated protein kinase 1c; MAP kinase-activated protein kinase 1c; 90 kDa ribosomal protein S6 kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.227 nM | [1] | ||
Co-Target Name | PAK-1 protein kinase (PAK1) | Literature-reported Target | ||||
UniProt ID | PAK1_HUMAN | |||||
Gene Name | PAK1 | |||||
Synonyms |
p65-PAK; p21-activated kinase 1; Serine/threonine-protein kinase PAK 1; PAK-1; Alpha-PAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.3 nM | [3] | ||
Co-Target Name | Proto-oncogene c-Fer (FER) | Literature-reported Target | ||||
UniProt ID | FER_HUMAN | |||||
Gene Name | FER | |||||
Synonyms |
p94-Fer; Tyrosine-protein kinase Fer; Tyrosine kinase 3; TYK3; Fujinami poultry sarcoma/Feline sarcoma-related protein Fer; Feline encephalitis virus-related kinase FER
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.365 nM | [1] | ||
Co-Target Name | Salt-inducible kinase 2 (SIK2) | Clinical trial Target | ||||
UniProt ID | SIK2_HUMAN | |||||
Gene Name | SIK2 | |||||
Synonyms |
Serine/threonine-protein kinase SNF1-like kinase 2; Serine/threonine-protein kinase SIK2; SNF1LK2; SIK-2; Qin-induced kinase; QIK; KIAA0781
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.37 nM | [1] | ||
Co-Target Name | TRAF2 and NCK interacting kinase (TNIK) | Literature-reported Target | ||||
UniProt ID | TNIK_HUMAN | |||||
Gene Name | TNIK | |||||
Synonyms |
TRAF2 and NCK-interacting protein kinase; KIAA0551
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.551 nM | [1] | ||
Co-Target Name | Non-receptor tyrosine-protein kinase TNK1 (TNK1) | Literature-reported Target | ||||
UniProt ID | TNK1_HUMAN | |||||
Gene Name | TNK1 | |||||
Synonyms |
CD38 negative kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.584 nM | [1] | ||
Co-Target Name | NDR1 protein kinase (STK38) | Literature-reported Target | ||||
UniProt ID | STK38_HUMAN | |||||
Gene Name | STK38 | |||||
Synonyms |
Serine/threonine-protein kinase 38; Nuclear Dbf2-related kinase 1; NDR1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.628 nM | [1] | ||
Co-Target Name | BR serine/threonine kinase 1 (BRSK1) | Literature-reported Target | ||||
UniProt ID | BRSK1_HUMAN | |||||
Gene Name | BRSK1 | |||||
Synonyms |
hSAD1; Synapses of Amphids Defective homolog 1; Serine/threonine-protein kinase SAD-B; Serine/threonine-protein kinase BRSK1; SADB; SAD1 homolog; SAD1; KIAA1811; Brain-specific serine/threonine-protein kinase 1; Brain-selective kinase 1; BR serine/threonine-protein kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.856 nM | [1] | ||
Co-Target Name | HUMAN protein kinase cAMP-activated catalytic subunit alpha (PRKACA) | Literature-reported Target | ||||
UniProt ID | KAPCA_HUMAN | |||||
Gene Name | PRKACA | |||||
Synonyms |
PKA C-alpha; cAMP-dependent protein kinase catalytic subunit alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.935 nM | [1] | ||
Co-Target Name | PAK-2 protein kinase (PAK2) | Literature-reported Target | ||||
UniProt ID | PAK2_HUMAN | |||||
Gene Name | PAK2 | |||||
Synonyms |
p21-activated kinase 2; Serine/threonine-protein kinase PAK 2; S6/H4 kinase; PAK65; PAK-2; Gamma-PAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1 nM | [4] | ||
Co-Target Name | Protein kinase N1 (PKN1) | Literature-reported Target | ||||
UniProt ID | PKN1_HUMAN | |||||
Gene Name | PKN1 | |||||
Synonyms |
Serine/threonine-protein kinase N1; Serine-threonine protein kinase N; Protein-kinase C-related kinase 1; Protein kinase PKN-alpha; Protein kinase C-like PKN; Protein kinase C-like 1; Protease-activated kinase 1; PRKCL1; PRK1; PKN; PAK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1 nM | [40] | ||
Co-Target Name | Tyrosine-protein kinase Fgr (FGR) | Literature-reported Target | ||||
UniProt ID | FGR_HUMAN | |||||
Gene Name | FGR | |||||
Synonyms |
p58c-Fgr; p58-Fgr; p55-Fgr; SRC2; Proto-oncogene c-Fgr; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.15 nM | [1] | ||
Co-Target Name | TAO kinase 1 (TAOK1) | Literature-reported Target | ||||
UniProt ID | TAOK1_HUMAN | |||||
Gene Name | TAOK1 | |||||
Synonyms |
hTAOK1; hKFC-B; Thousand and one amino acid protein kinase 1; TAOK1; Serine/threonine-protein kinase TAO1; Prostate-derived sterile 20-like kinase 2; Prostate-derived STE20-like kinase 2; PSK2; PSK-2; MARKK; MARK Kinase; MAP3K16; Kinase from chicken homolog B; KIAA1361
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.21 nM | [1] | ||
Co-Target Name | Protein kinase G1 (PRKG1) | Literature-reported Target | ||||
UniProt ID | KGP1_HUMAN | |||||
Gene Name | PRKG1 | |||||
Synonyms |
cGMP-dependent protein kinase I; cGMP-dependent protein kinase 1; cGKI; cGK1; cGK 1; PRKGR1B; PRKGR1A; PRKG1B
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.23 nM | [1] | ||
Co-Target Name | SIK family kinase 3 (SIK3) | Clinical trial Target | ||||
UniProt ID | SIK3_HUMAN | |||||
Gene Name | SIK3 | |||||
Synonyms |
Serine/threonine-protein kinase SIK3; Serine/threonine-protein kinase QSK; Salt-inducible kinase 3; SIK-3; KIAA0999
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.24 nM | [1] | ||
Co-Target Name | Omphalocele kinase 1 (NUAK1) | Literature-reported Target | ||||
UniProt ID | NUAK1_HUMAN | |||||
Gene Name | NUAK1 | |||||
Synonyms |
OMPHK1; NUAK family SNF1-like kinase 1; KIAA0537; ARK5; AMPK-related protein kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.31 nM | [41] | ||
Co-Target Name | Salt-inducible kinase 1 (SIK1) | Literature-reported Target | ||||
UniProt ID | SIK1_HUMAN | |||||
Gene Name | SIK1 | |||||
Synonyms |
Serine/threonine-protein kinase SNF1LK; Serine/threonine-protein kinase SNF1-like kinase 1; Serine/threonine-protein kinase SIK1; SNF1LK; SIK-1; SIK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.34 nM | [1] | ||
Co-Target Name | NDR2 protein kinase (STK38L) | Literature-reported Target | ||||
UniProt ID | ST38L_HUMAN | |||||
Gene Name | STK38L | |||||
Synonyms |
Serine/threonine-protein kinase 38-like; Nuclear Dbf2-related kinase 2; NDR2; KIAA0965
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.47 nM | [1] | ||
Co-Target Name | Proto-oncogene c-Fes (FES) | Literature-reported Target | ||||
UniProt ID | FES_HUMAN | |||||
Gene Name | FES | |||||
Synonyms |
p93c-fes; Tyrosine-protein kinase Fes/Fps; Proto-oncogene c-Fps; Feline sarcoma/Fujinami avian sarcoma oncogene homolog; FPS
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.52 nM | [1] | ||
Co-Target Name | MST-1 protein kinase (STK4) | Literature-reported Target | ||||
UniProt ID | STK4_HUMAN | |||||
Gene Name | STK4 | |||||
Synonyms |
Serine/threonine-protein kinase Krs-2; Serine/threonine-protein kinase 4 18kDa subunit; Serine/threonine-protein kinase 4; STE20-like kinase MST1; Mammalian STE20-like protein kinase 1; MST1/N; MST1/C; MST1; MST-1; KRS2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.58 nM | [1] | ||
Co-Target Name | NUAK family SNF1-like kinase 2 (NUAK2) | Literature-reported Target | ||||
UniProt ID | NUAK2_HUMAN | |||||
Gene Name | NUAK2 | |||||
Synonyms |
SNF1/AMP kinase-related kinase; SNARK; Omphalocele kinase 2; OMPHK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.67 nM | [1] | ||
Co-Target Name | Protein kinase N2 (PKN2) | Literature-reported Target | ||||
UniProt ID | PKN2_HUMAN | |||||
Gene Name | PKN2 | |||||
Synonyms |
Serine/threonine-protein kinase N2; Protein-kinase C-related kinase 2; Protein kinase C-like 2; PRKCL2; PRK2; PKN gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.97 nM | [41] | ||
Co-Target Name | TAO kinase 3 (TAOK3) | Literature-reported Target | ||||
UniProt ID | TAOK3_HUMAN | |||||
Gene Name | TAOK3 | |||||
Synonyms |
hKFC-A; Thousand and one amino acid protein 3; Serine/threonine-protein kinase TAO3; MAP3K18; Kinase from chicken homolog A; KDS; Jun kinase-inhibitory kinase; JNK/SAPK-inhibitory kinase; JIK; Dendritic cell-derived protein kinase; DPK; Cutaneous T-cell lymphoma-associated antigen HD-CL-09; CTCL-associated antigen HD-CL-09
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.11 nM | [1] | ||
Co-Target Name | BR serine/threonine kinase 2 (BRSK2) | Literature-reported Target | ||||
UniProt ID | BRSK2_HUMAN | |||||
Gene Name | BRSK2 | |||||
Synonyms |
Serine/threonine-protein kinase SAD-A; Serine/threonine-protein kinase BRSK2; Serine/threonine-protein kinase 29; STK29; SADA; PEN11B; HUSSY-12; C11orf7; Brain-specific serine/threonine-protein kinase 2; Brain-selective kinase 2; BR serine/threonine-protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.33 nM | [1] | ||
Co-Target Name | LIM domain kinase-1 (LIMK-1) | Literature-reported Target | ||||
UniProt ID | LIMK1_HUMAN | |||||
Gene Name | LIMK1 | |||||
Synonyms |
LIMK-1; LIMK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.44 nM | [1] | ||
Co-Target Name | Mixed lineage kinase 2 (MAP3K10) | Literature-reported Target | ||||
UniProt ID | M3K10_HUMAN | |||||
Gene Name | MAP3K10 | |||||
Synonyms |
Protein kinase MST; Mitogen-activated protein kinase kinase kinase 10; MST; MLK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.69 nM | [1] | ||
Co-Target Name | Death-associated protein kinase 3 (DAPK3) | Literature-reported Target | ||||
UniProt ID | DAPK3_HUMAN | |||||
Gene Name | DAPK3 | |||||
Synonyms |
Zipper-interacting protein kinase; ZIPK; ZIP-kinase; MYPT1 kinase; DAP-like kinase; DAP kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.45 nM | [1] | ||
Co-Target Name | Leukocyte receptor tyrosine kinase (LTK) | Literature-reported Target | ||||
UniProt ID | LTK_HUMAN | |||||
Gene Name | LTK | |||||
Synonyms |
TYK1; Protein tyrosine kinase 1; Leukocyte tyrosine kinase receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.6 nM | [7] | ||
Co-Target Name | Large tumor suppressor homolog 2 (LATS2) | Literature-reported Target | ||||
UniProt ID | LATS2_HUMAN | |||||
Gene Name | LATS2 | |||||
Synonyms |
Warts-like kinase; Serine/threonine-protein kinase kpm; Serine/threonine-protein kinase LATS2; Kinase phosphorylated during mitosis protein; KPM
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.76 nM | [1] | ||
Co-Target Name | Muscle-specific kinase receptor (MUSK) | Literature-reported Target | ||||
UniProt ID | MUSK_HUMAN | |||||
Gene Name | MUSK | |||||
Synonyms |
Muscle-specific tyrosine-protein kinase receptor; Muscle, skeletal receptor tyrosine-protein kinase; MuSK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.8 nM | [7] | ||
Co-Target Name | Mixed lineage kinase 3 (MAP3K11) | Literature-reported Target | ||||
UniProt ID | M3K11_HUMAN | |||||
Gene Name | MAP3K11 | |||||
Synonyms |
Src-homology 3 domain-containing proline-rich kinase; SPRK; SH3 domain-containing proline-rich kinase; Protein-tyrosine kinase PTK1; PTK1; Mixed-lineage protein kinase 3; Mitogen-activated protein kinase kinase kinase 11; MLK3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4 nM | [1] | ||
Co-Target Name | Unc-51 like kinase 3 (ULK3) | Literature-reported Target | ||||
UniProt ID | ULK3_HUMAN | |||||
Gene Name | ULK3 | |||||
Synonyms |
Unc-51-like kinase 3; Serine/threonine-protein kinase ULK3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.2 nM | [1] | ||
Co-Target Name | Testis-specific serine kinase 2 (TSSK2) | Literature-reported Target | ||||
UniProt ID | TSSK2_HUMAN | |||||
Gene Name | TSSK2 | |||||
Synonyms |
Testis-specific serine/threonine-protein kinase 2; TSSK-2; TSK2; TSK-2; Serine/threonine-protein kinase 22B; STK22B; SPOGA2; DiGeorge syndrome protein G; DGSG; DGS-G
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.32 nM | [1] | ||
Co-Target Name | CDC42 binding protein kinase alpha (DMPK-like alpha) | Literature-reported Target | ||||
UniProt ID | MRCKA_HUMAN | |||||
Gene Name | CDC42BPA | |||||
Synonyms |
Serine/threonine-protein kinase MRCK alpha; Myotonic dystrophy protein kinase-like alpha; Myotonic dystrophy kinase-related CDC42-binding kinase alpha; MRCK alpha; KIAA0451; CDC42-binding protein kinase alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.35 nM | [1] | ||
Co-Target Name | Protein kinase G2 (PRKG2) | Literature-reported Target | ||||
UniProt ID | KGP2_HUMAN | |||||
Gene Name | PRKG2 | |||||
Synonyms |
cGMP-dependent protein kinase II; cGMP-dependent protein kinase 2; cGKII; cGK2; cGK 2; PRKGR2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.77 nM | [1] | ||
Co-Target Name | RAC-beta serine/threonine-protein kinase (AKT2) | Literature-reported Target | ||||
UniProt ID | AKT2_HUMAN | |||||
Gene Name | AKT2 | |||||
Synonyms |
RAC-PK-beta; Protein kinase B beta; Protein kinase Akt-2; PKB beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.5 nM | [42] | ||
Co-Target Name | Serine/threonine-protein kinase ULK1 (ULK1) | Literature-reported Target | ||||
UniProt ID | ULK1_HUMAN | |||||
Gene Name | ULK1 | |||||
Synonyms |
hATG1; Unc-51-like kinase 1; KIAA0722; Autophagy-related protein 1 homolog; ATG1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 8.95 nM | [1] | ||
Co-Target Name | Polo-like kinase 4 (PLK4) | Literature-reported Target | ||||
UniProt ID | PLK4_HUMAN | |||||
Gene Name | PLK4 | |||||
Synonyms |
Serine/threonine-protein kinase Sak; Serine/threonine-protein kinase PLK4; Serine/threonine-protein kinase 18; STK18; SAK; PLK-4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 9.49 nM | [1] | ||
Co-Target Name | Focal adhesion kinase 2 (PTK2B) | Literature-reported Target | ||||
UniProt ID | FAK2_HUMAN | |||||
Gene Name | PTK2B | |||||
Synonyms |
Related adhesion focal tyrosine kinase; RAFTK; Protein-tyrosine kinase 2-beta; Proline-rich tyrosine kinase 2; PYK2; FAK2; FADK 2; Cell adhesion kinase beta; Calcium-regulated non-receptor proline-rich tyrosine kinase; Calcium-dependent tyrosine kinase; CAKB; CAK-beta; CADTK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10.6 nM | [1] | ||
Co-Target Name | MAPK/ERK kinase kinase 3 (MAP3K3) | Literature-reported Target | ||||
UniProt ID | M3K3_HUMAN | |||||
Gene Name | MAP3K3 | |||||
Synonyms |
Mitogen-activated protein kinase kinase kinase 3; MEKK3; MEKK 3; MEK kinase 3; MAPKKK3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 10.9 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 6 (EPHA6) | Literature-reported Target | ||||
UniProt ID | EPHA6_HUMAN | |||||
Gene Name | EPHA6 | |||||
Synonyms |
HEK12; EPH-like kinase 12; EPH homology kinase 2; EK12; EHK2; EHK-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11.8 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 4 (EPHA4) | Literature-reported Target | ||||
UniProt ID | EPHA4_HUMAN | |||||
Gene Name | EPHA4 | |||||
Synonyms |
hEK8; Tyrosineprotein kinase receptor SEK; Tyrosineprotein kinase TYRO1; Tyrosine-protein kinase receptor SEK; Tyrosine-protein kinase TYRO1; TYRO1; SEK; Ephrin typeA receptor 4; EPHlike kinase 8; EPH-like kinase 8; EK8
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 12.5 nM | [1] | ||
Co-Target Name | Myosin light chain kinase 2 (MYLK2) | Literature-reported Target | ||||
UniProt ID | MYLK2_HUMAN | |||||
Gene Name | MYLK2 | |||||
Synonyms |
MYLK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 13.9 nM | [1] | ||
Co-Target Name | Ste-20-related kinase (STK39) | Literature-reported Target | ||||
UniProt ID | STK39_HUMAN | |||||
Gene Name | STK39 | |||||
Synonyms |
Serine/threonine-protein kinase 39; STE20/SPS1-related proline-alanine-rich protein kinase; SPAK; DCHT
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 14.4 nM | [1] | ||
Co-Target Name | STE20-related serine/threonine-protein kinase (SLK) | Literature-reported Target | ||||
UniProt ID | SLK_HUMAN | |||||
Gene Name | SLK | |||||
Synonyms |
hSLK; STE20-related kinase; STE20-like kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 14.6 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase ABL2 (ABL2) | Literature-reported Target | ||||
UniProt ID | ABL2_HUMAN | |||||
Gene Name | ABL2 | |||||
Synonyms |
Tyrosine-protein kinase ARG; Abelson-related gene protein; Abelson tyrosine-protein kinase 2; Abelson murine leukemia viral oncogene homolog 2; ARG; ABLL
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 15.8 nM | [1] | ||
Co-Target Name | PAS domain-containing serine/threonine-protein kinase (PASK) | Literature-reported Target | ||||
UniProt ID | PASK_HUMAN | |||||
Gene Name | PASK | |||||
Synonyms |
hPASK; PASKIN; PAS-kinase; KIAA0135
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 15.8 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Nek8 (NEK8) | Literature-reported Target | ||||
UniProt ID | NEK8_HUMAN | |||||
Gene Name | NEK8 | |||||
Synonyms |
Nima-related protein kinase 12a; NimA-related protein kinase 8; Never in mitosis A-related kinase 8; NEK12A; JCK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 17.5 nM | [1] | ||
Co-Target Name | NIMA-related kinase 1 (NEK1) | Literature-reported Target | ||||
UniProt ID | NEK1_HUMAN | |||||
Gene Name | NEK1 | |||||
Synonyms |
Serine/threonine-protein kinase Nek1; Renal carcinoma antigen NY-REN-55; NimA-related protein kinase 1; Never in mitosis A-related kinase 1; KIAA1901
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 18.4 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 5 (EPHA5) | Literature-reported Target | ||||
UniProt ID | EPHA5_HUMAN | |||||
Gene Name | EPHA5 | |||||
Synonyms |
hEK7; EPH-like kinase 7; EPH homology kinase 1; EK7; EHK1; EHK-1; Brain-specific kinase; BSK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 21.5 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase TXK (TXK) | Literature-reported Target | ||||
UniProt ID | TXK_HUMAN | |||||
Gene Name | TXK | |||||
Synonyms |
Resting lymphocyte kinase; RLK; Protein-tyrosine kinase 4; PTK4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 21.6 nM | [1] | ||
Co-Target Name | Cytoplasmic DRAK1 (STK17A) | Literature-reported Target | ||||
UniProt ID | ST17A_HUMAN | |||||
Gene Name | STK17A | |||||
Synonyms |
Serine/threonine-protein kinase 17A; STK17A; DAP kinase-related apoptosis-inducing protein kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 30.4 nM | [1] | ||
Co-Target Name | CDC-like kinase 4 (CLK4) | Literature-reported Target | ||||
UniProt ID | CLK4_HUMAN | |||||
Gene Name | CLK4 | |||||
Synonyms |
Dual specificity protein kinase CLK4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 33.6 nM | [1] | ||
Co-Target Name | TGF-beta-activated kinase 1 (MAP3K7) | Literature-reported Target | ||||
UniProt ID | M3K7_HUMAN | |||||
Gene Name | MAP3K7 | |||||
Synonyms |
Transforming growth factor-beta-activated kinase 1; TAK1; Mitogen-activated protein kinase kinase kinase 7
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 35 nM | [4] | ||
Co-Target Name | Serine/threonine-protein kinase 33 (STK33) | Literature-reported Target | ||||
UniProt ID | STK33_HUMAN | |||||
Gene Name | STK33 | |||||
Synonyms |
STK33
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 36.3 nM | [1] | ||
Co-Target Name | Inhibitor of nuclear factor kappa-B kinase alpha (IKKA) | Literature-reported Target | ||||
UniProt ID | IKKA_HUMAN | |||||
Gene Name | CHUK | |||||
Synonyms |
Transcription factor 16; TCF16; TCF-16; Nuclear factor NFkappaB inhibitor kinase alpha; Nuclear factor NF-kappa-B inhibitor kinase alpha; NFKBIKA; Inhibitory kappa B kinasea; Inhibitor of nuclear factor kappa-B kinase subunit alpha; IkappaB kinase A; IkBKA; IKK1; IKK-alpha; IKK-A; I-kappa-B kinase alpha; I-kappa-B kinase 1; I kappa-B kinase alpha; Conserved helix-loop-helix ubiquitous kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 39 nM | [43] | ||
Co-Target Name | ERK activator kinase 5 (MAP2K5) | Literature-reported Target | ||||
UniProt ID | MP2K5_HUMAN | |||||
Gene Name | MAP2K5 | |||||
Synonyms |
PRKMK5; Mitogen-activatedprotein kinase kinase 5; MKK5; MEK5; MEK 5; MAPKK 5; MAPK/ERK kinase 5; MAP kinase kinase5; MAP kinase kinase 5; Dual specificity mitogen-activated protein kinase kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 40.4 nM | [1] | ||
Co-Target Name | CaM-kinase IV kinase (CAMKK1) | Literature-reported Target | ||||
UniProt ID | KKCC1_HUMAN | |||||
Gene Name | CAMKK1 | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase kinase alpha; Calcium/calmodulin-dependent protein kinase kinase 1; CaMKK alpha; CaMKK 1; CaM-kinase kinase alpha; CaM-kinase kinase 1; CaM-KK alpha; CaM-KK 1; CAMKKA
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 42 nM | [1] | ||
Co-Target Name | Yet another novel kinase 2 (STK32B) | Literature-reported Target | ||||
UniProt ID | ST32B_HUMAN | |||||
Gene Name | STK32B | |||||
Synonyms |
YANK2; Serine/threonine-protein kinase 32B
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 49.1 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 1 (EPHA1) | Literature-reported Target | ||||
UniProt ID | EPHA1_HUMAN | |||||
Gene Name | EPHA1 | |||||
Synonyms |
hEpha1; Tyrosine-protein kinase receptor EPH; Erythropoietin-producing hepatoma receptor; EPHT1; EPHT; EPH tyrosine kinase 1; EPH tyrosine kinase; EPH
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 49.8 nM | [7] | ||
Co-Target Name | Ephrin type-A receptor 7 (EPHA7) | Literature-reported Target | ||||
UniProt ID | EPHA7_HUMAN | |||||
Gene Name | EPHA7 | |||||
Synonyms |
hEK11; EPH-like kinase 11; EPH homology kinase 3; EK11; EHK3; EHK-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 56.3 nM | [1] | ||
Co-Target Name | Ephrin type-B receptor 1 (EPHB1) | Literature-reported Target | ||||
UniProt ID | EPHB1_HUMAN | |||||
Gene Name | EPHB1 | |||||
Synonyms |
hEK6; Tyrosine-protein kinase receptor EPH-2; Neuronally-expressed EPH-related tyrosine kinase; EPHT2; EPH-like kinase 6; EPH tyrosine kinase 2; ELK; EK6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 60.3 nM | [1] | ||
Co-Target Name | Doublecortin-like kinase 2 (DCLK2) | Literature-reported Target | ||||
UniProt ID | DCLK2_HUMAN | |||||
Gene Name | DCLK2 | |||||
Synonyms |
Serine/threonine-protein kinase DCLK2; Doublecortin-like and CAM kinase-like 2; Doublecortin domain-containing protein 3B; DCK2; DCDC3B; DCAMKL2; CaMK-like CREB regulatory kinase 2; CLICK2; CLICK-II; CL2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 83.5 nM | [1] | ||
Co-Target Name | PDZ binding kinase (PBK) | Literature-reported Target | ||||
UniProt ID | TOPK_HUMAN | |||||
Gene Name | PBK | |||||
Synonyms |
TOPK; T-LAK cell-originated protein kinase; Spermatogenesis-related protein kinase; SPK protein; PDZ-binding kinase; Nori-3; MAPKK-like protein kinase; Lymphokine-activated killer T-cell-originated protein kinase; Cancer/testis antigen 84; CT84
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 83.9 nM | [1] | ||
Co-Target Name | LIM domain kinase-2 (LIMK-2) | Literature-reported Target | ||||
UniProt ID | LIMK2_HUMAN | |||||
Gene Name | LIMK2 | |||||
Synonyms |
LIMK-2; LIM domain kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 102 nM | [1] | ||
Co-Target Name | HUMAN NIMA related kinase 9 (NEK9) | Literature-reported Target | ||||
UniProt ID | NEK9_HUMAN | |||||
Gene Name | NEK9 | |||||
Synonyms |
Serine/threonine-protein kinase Nek9; NimA-related protein kinase 9; NimA-related kinase 8; Never in mitosis A-related kinase 9; Nercc1 kinase; Nek8
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 131 nM | [1] | ||
Co-Target Name | Ephrin type-A receptor 8 (EPHA8) | Literature-reported Target | ||||
UniProt ID | EPHA8_HUMAN | |||||
Gene Name | EPHA8 | |||||
Synonyms |
hEK3; Tyrosine-protein kinase receptor EEK; KIAA1459; EPH-like kinase 3; EPH- and ELK-related kinase; EK3; EEK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 137 nM | [1] | ||
Co-Target Name | Doublecortin-like kinase 1 (DCLK1) | Literature-reported Target | ||||
UniProt ID | DCLK1_HUMAN | |||||
Gene Name | DCLK1 | |||||
Synonyms |
Serine/threonine-protein kinase DCLK1; KIAA0369; Doublecortin-like and CAM kinase-like 1; Doublecortin domain-containing protein 3A; DCDC3A; DCAMKL1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 173 nM | [1] | ||
Co-Target Name | SRSF protein kinase 2 (SRPK2) | Literature-reported Target | ||||
UniProt ID | SRPK2_HUMAN | |||||
Gene Name | SRPK2 | |||||
Synonyms |
Serine/arginine-rich protein-specific kinase 2; SR-protein-specific kinase 2; SFRS protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 227 nM | [1] | ||
Co-Target Name | TGF-beta-stimulated factor 1 (STK16) | Literature-reported Target | ||||
UniProt ID | STK16_HUMAN | |||||
Gene Name | STK16 | |||||
Synonyms |
hPSK; Tyrosine-protein kinase STK16; TSF1; TSF-1; Serine/threonine-protein kinase 16; Protein kinase PKL12; PKL12; Myristoylated and palmitoylated serine/threonine-protein kinase; MPSK1; MPSK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 235 nM | [1] | ||
Co-Target Name | Testis-specific kinase 1 (TESK1) | Literature-reported Target | ||||
UniProt ID | TESK1_HUMAN | |||||
Gene Name | TESK1 | |||||
Synonyms |
Testicular protein kinase 1; Dual specificity testis-specific protein kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 261 nM | [1] | ||
Co-Target Name | NIMA-related kinase 2 (NEK2) | Literature-reported Target | ||||
UniProt ID | NEK2_HUMAN | |||||
Gene Name | NEK2 | |||||
Synonyms |
Serine/threonine-protein kinase Nek2; NimA-related protein kinase 2; NimA-like protein kinase 1; Never in mitosis A-related kinase 2; NLK1; NEK2A; HSPK 21
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 345 nM | [1] | ||
Co-Target Name | Apoptosis signal-regulating kinase 2 (MAP3K6) | Literature-reported Target | ||||
UniProt ID | M3K6_HUMAN | |||||
Gene Name | MAP3K6 | |||||
Synonyms |
MAP3K6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 475 nM | [1] | ||
Co-Target Name | Homeodomain interacting protein kinase 2 (HIPK2) | Literature-reported Target | ||||
UniProt ID | HIPK2_HUMAN | |||||
Gene Name | HIPK2 | |||||
Synonyms |
hHIPk2; Homeodomain-interacting protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 585 nM | [1] | ||
Co-Target Name | Beta-adrenergic receptor kinase 2 (ADRBK2) | Literature-reported Target | ||||
UniProt ID | ARBK2_HUMAN | |||||
Gene Name | GRK3 | |||||
Synonyms |
G-protein-coupled receptor kinase 3; Beta-ARK-2; BARK2; ADRBK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 850 nM | [1] | ||
Co-Target Name | CaM kinase II delta (CAMK2D) | Co-Target | ||||
UniProt ID | KCC2D_HUMAN | |||||
Gene Name | CAMK2D | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type II subunit delta; CaM kinase II subunit delta; CaMK-II subunit delta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.0311 nM | [1] | ||
Co-Target Name | Testis-specific serine/threonine-protein kinase 1 (TSSK1B) | Co-Target | ||||
UniProt ID | TSSK1_HUMAN | |||||
Gene Name | TSSK1B | |||||
Synonyms |
TSK-1; TSK1; TSSK-1; Testis-specific kinase 1; Serine/threonine-protein kinase 22A
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.052 nM | [1] | ||
Co-Target Name | CaM kinase II alpha (CAMK2A) | Co-Target | ||||
UniProt ID | KCC2A_HUMAN | |||||
Gene Name | CAMK2A | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type II subunit alpha; CaM kinase II subunit alpha; CaMK-II subunit alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.0635 nM | [1] | ||
Co-Target Name | CaM kinase II beta (CAMK2B) | Co-Target | ||||
UniProt ID | KCC2B_HUMAN | |||||
Gene Name | CAMK2B | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type II subunit beta; CaM kinase II subunit beta; CaMK-II subunit beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.07 nM | [3] | ||
Co-Target Name | MAP/microtubule affinity-regulating kinase 4 (MARK4) | Co-Target | ||||
UniProt ID | MARK4_HUMAN | |||||
Gene Name | MARK4 | |||||
Synonyms |
MAP/microtubule affinity-regulating kinase-like 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.114 nM | [1] | ||
Co-Target Name | CaM kinase I delta (CAMK1D) | Co-Target | ||||
UniProt ID | KCC1D_HUMAN | |||||
Gene Name | CAMK1D | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type 1D; CaM kinase ID; CaM-KI delta; CaMKI delta; CaMKID; CaMKI-like protein kinase; CKLiK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.298 nM | [1] | ||
Co-Target Name | Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5) | Co-Target | ||||
UniProt ID | M4K5_HUMAN | |||||
Gene Name | MAP4K5 | |||||
Synonyms |
Kinase homologous to SPS1/STE20; KHS; MAPK/ERK kinase kinase kinase 5; MEK kinase kinase 5; MEKKK 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.309 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 3 (PAK3) | Co-Target | ||||
UniProt ID | PAK3_HUMAN | |||||
Gene Name | PAK3 | |||||
Synonyms |
Beta-PAK; Oligophrenin-3; p21-activated kinase 3; PAK-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.343 nM | [1] | ||
Co-Target Name | CaM kinase II gamma (CAMK2G) | Co-Target | ||||
UniProt ID | KCC2G_HUMAN | |||||
Gene Name | CAMK2G | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type II subunit gamma; CaM kinase II subunit gamma; CaMK-II subunit gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.387 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin A2 complex (CDK2-CCNA2) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNA2_HUMAN | |||||
Gene Name | CDK2-CCNA2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.4 nM | [44] | ||
Co-Target Name | Serine/threonine-protein kinase MST2 (STK3) | Co-Target | ||||
UniProt ID | STK3_HUMAN | |||||
Gene Name | STK3 | |||||
Synonyms |
Serine/threonine-protein kinase 3; Mammalian STE20-like protein kinase 2; MST-2; STE20-like kinase MST2; Serine/threonine-protein kinase Krs-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.41 nM | [4] | ||
Co-Target Name | Serine/threonine-protein kinase MARK1 (MARK1) | Co-Target | ||||
UniProt ID | MARK1_HUMAN | |||||
Gene Name | MARK1 | |||||
Synonyms |
MAP/microtubule affinity-regulating kinase 1; PAR1 homolog c; Par-1c; Par1c
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.417 nM | [1] | ||
Co-Target Name | Inhibitor of nuclear factor kappa B kinase epsilon (IKBKE) | Co-Target | ||||
UniProt ID | IKKE_HUMAN | |||||
Gene Name | IKBKE | |||||
Synonyms |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon; I-kappa-B kinase epsilon; IKK-E; IKK-epsilon; IkBKE; Inducible I kappa-B kinase; IKK-i
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.439 nM | [1] | ||
Co-Target Name | Misshapen-like kinase 1 (MINK1) | Co-Target | ||||
UniProt ID | MINK1_HUMAN | |||||
Gene Name | MINK1 | |||||
Synonyms |
GCK family kinase MiNK; MAPK/ERK kinase kinase kinase 6; MEK kinase kinase 6; MEKKK 6; Misshapen/NIK-related kinase; Mitogen-activated protein kinase kinase kinase kinase 6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.451 nM | [1] | ||
Co-Target Name | Phosphorylase kinase (PHK) | Co-Target | ||||
UniProt ID | KPB1_HUMAN; KPB2_HUMAN; KPBB_HUMAN; PHKG1_HUMAN; PHKG2_HUMAN | |||||
Gene Name | PHKA1; PHKA2; PHKB; PHKG1; PHKG2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.5 nM | [45] | ||
Co-Target Name | Death-associated protein kinase 1 (DAPK1) | Co-Target | ||||
UniProt ID | DAPK1_HUMAN | |||||
Gene Name | DAPK1 | |||||
Synonyms |
DAP kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.5 nM | [4] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin A1 complex (CDK2-CCNA1) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNA1_HUMAN | |||||
Gene Name | CDK2-CCNA1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.5 nM | [44] | ||
Co-Target Name | Serine/threonine-protein kinase MRCK gamma (CDC42BPG) | Co-Target | ||||
UniProt ID | MRCKG_HUMAN | |||||
Gene Name | CDC42BPG | |||||
Synonyms |
CDC42-binding protein kinase gamma; DMPK-like gamma; Myotonic dystrophy kinase-related CDC42-binding kinase gamma; MRCK gamma; MRCKG; Myotonic dystrophy protein kinase-like gamma; Myotonic dystrophy protein kinase-like alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.848 nM | [1] | ||
Co-Target Name | Lysyl-tRNA synthetase (KARS1) | Co-Target | ||||
UniProt ID | SYK_HUMAN | |||||
Gene Name | KARS1 | |||||
Synonyms |
Lysine--tRNA ligase; LysRS
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.86 nM | [36] | ||
Co-Target Name | cAMP-dependent protein kinase (PKA) | Co-Target | ||||
UniProt ID | KAPCA_HUMAN; KAPCB_HUMAN; KAPCG_HUMAN | |||||
Gene Name | PRKACA; PRKACB; PRKACG | |||||
Synonyms |
PKA C
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 0.9 nM | [10] | ||
Co-Target Name | Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4) | Co-Target | ||||
UniProt ID | MP2K4_HUMAN | |||||
Gene Name | MAP2K4 | |||||
Synonyms |
MAP kinase kinase 4; MAPKK 4; JNK-activating kinase 1; MAPK/ERK kinase 4; MEK 4; SAPK/ERK kinase 1; SEK1; Stress-activated protein kinase kinase 1; SAPK kinase 1; SAPKK-1; SAPKK1; c-Jun N-terminal kinase kinase 1; JNKK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 1 nM | [25] | ||
Co-Target Name | Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6) | Co-Target | ||||
UniProt ID | MP2K6_HUMAN | |||||
Gene Name | MAP2K6 | |||||
Synonyms |
MAP kinase kinase 6; MAPKK 6; MAPK/ERK kinase 6; MEK 6; Stress-activated protein kinase kinase 3; SAPK kinase 3; SAPKK-3; SAPKK3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 1 nM | [25] | ||
Co-Target Name | Cyclin dependent kinase 2-G1/S specific cyclin E complex (CDK2-CCNE) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNE1_HUMAN/CCNE2_HUMAN | |||||
Gene Name | CDK2-CCNE1/CCNE2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 < 1 nM | [12] | ||
Co-Target Name | cAMP-dependent protein kinase beta-1 (PRKACB) | Co-Target | ||||
UniProt ID | KAPCB_HUMAN | |||||
Gene Name | PRKACB | |||||
Synonyms |
cAMP-dependent protein kinase catalytic subunit beta; PKA C-beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.2 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 5-CDK5 activator 1 complex (CDK5-CDK5R1) | Co-Target | ||||
UniProt ID | CDK5_HUMAN-CD5R1_HUMAN | |||||
Gene Name | CDK5-CDK5R1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.2 nM | [44] | ||
Co-Target Name | Cyclin dependent kinase 1-G2/mitotic specific cyclin B1 complex (CDK1-CCNB1) | Co-Target | ||||
UniProt ID | CDK1_HUMAN-CCNB1_HUMAN | |||||
Gene Name | CDK1-CCNB1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.3 nM | [46] | ||
Co-Target Name | Serine/threonine-protein kinase D2 (PRKD2) | Co-Target | ||||
UniProt ID | KPCD2_HUMAN | |||||
Gene Name | PRKD2 | |||||
Synonyms |
nPKC-D2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.33 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PRKX (PRKX) | Co-Target | ||||
UniProt ID | PRKX_HUMAN | |||||
Gene Name | PRKX | |||||
Synonyms |
cAMP-dependent protein kinase catalytic subunit PRKX; PrKX; Protein kinase X; Protein kinase X-linked; Protein kinase PKX1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.39 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin O complex (CDK2-CCNO) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNO_HUMAN | |||||
Gene Name | CDK2-CCNO | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.46 nM | [41] | ||
Co-Target Name | Cyclin dependent kinase 2-G1/S specific cyclin E1 complex (CDK2-CCNE1) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNE1_HUMAN | |||||
Gene Name | CDK2-CCNE1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.67 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 1-Cyclin A2 complex (CDK1-CCNA2) | Co-Target | ||||
UniProt ID | CDK1_HUMAN-CCNA2_HUMAN | |||||
Gene Name | CDK1-CCNA2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.7 nM | [44] | ||
Co-Target Name | Serine/threonine-protein kinase 25 (STK25) | Co-Target | ||||
UniProt ID | STK25_HUMAN | |||||
Gene Name | STK25 | |||||
Synonyms |
Ste20-like kinase; Sterile 20/oxidant stress-response kinase 1; SOK-1; Ste20/oxidant stress response kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 1.9 nM | [41] | ||
Co-Target Name | Cyclin dependent kinase 3-G1/Sspecific cyclin E1 complex (CDK3-CCNE1) | Co-Target | ||||
UniProt ID | CDK3_HUMAN-CCNE1_HUMAN | |||||
Gene Name | CDK3-CCNE1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.08 nM | [41] | ||
Co-Target Name | Cyclin dependent kinase 1-G1/S specific Cyclin E1 complex (CDK1-CCNE) | Co-Target | ||||
UniProt ID | CDK1_HUMAN-CCNE1_HUMAN | |||||
Gene Name | CDK1-CCNE1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.17 nM | [3] | ||
Co-Target Name | Ribosomal protein S6 kinase beta 2 (RPS6KB2) | Co-Target | ||||
UniProt ID | KS6B2_HUMAN | |||||
Gene Name | RPS6KB2 | |||||
Synonyms |
Ribosomal protein S6 kinase beta-2; S6K-beta-2; S6K2; 70 kDa ribosomal protein S6 kinase 2; P70S6K2; p70-S6K 2; S6 kinase-related kinase; SRK; Serine/threonine-protein kinase 14B; p70 ribosomal S6 kinase beta; S6K-beta; p70 S6 kinase beta; p70 S6K-beta; p70 S6KB; p70-beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.35 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 1-G2/mitotic specific cyclin B complex (CDK1-CCNB) | Co-Target | ||||
UniProt ID | CDK1_HUMAN-CCNB1_HUMAN/CCNB2_HUMAN/CCNB3_HUMAN | |||||
Gene Name | CDK1-CCNB1/CCNB2/CCNB3 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.52 nM | [12] | ||
Co-Target Name | Phosphorylase kinase gamma 1 (PHKG1) | Co-Target | ||||
UniProt ID | PHKG1_HUMAN | |||||
Gene Name | PHKG1 | |||||
Synonyms |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform; PHK-gamma-M; Phosphorylase kinase subunit gamma-1; Serine/threonine-protein kinase PHKG1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.58 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase ULK2 (ULK2) | Co-Target | ||||
UniProt ID | ULK2_HUMAN | |||||
Gene Name | ULK2 | |||||
Synonyms |
Unc-51-like kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.67 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase MST4 (STK26) | Co-Target | ||||
UniProt ID | STK26_HUMAN | |||||
Gene Name | STK26 | |||||
Synonyms |
Serine/threonine-protein kinase 26; MST3 and SOK1-related kinase; Mammalian STE20-like protein kinase 4; MST-4; STE20-like kinase MST4; Serine/threonine-protein kinase MASK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.87 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 6-G1/S specific cyclin D1 complex (CDK6-CCND1) | Co-Target | ||||
UniProt ID | CDK6_HUMAN-CCND1_HUMAN | |||||
Gene Name | CDK6-CCND1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 2.9 nM | [44] | ||
Co-Target Name | CaM kinase I alpha (CAMK1) | Co-Target | ||||
UniProt ID | KCC1A_HUMAN | |||||
Gene Name | CAMK1 | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type 1; CaM kinase I; CaM-KI; CaMKI-alpha
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.02 nM | [1] | ||
Co-Target Name | Pseudopodium-enriched atypical kinase 1 (PEAK1) | Co-Target | ||||
UniProt ID | PEAK1_HUMAN | |||||
Gene Name | PEAK1 | |||||
Synonyms |
Inactive tyrosine-protein kinase PEAK1; Sugen kinase 269; Tyrosine-protein kinase SgK269
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.04 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase 24 (STK24) | Co-Target | ||||
UniProt ID | STK24_HUMAN | |||||
Gene Name | STK24 | |||||
Synonyms |
Mammalian STE20-like protein kinase 3; MST-3; STE20-like kinase MST3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.34 nM | [41] | ||
Co-Target Name | Serine/threonine-protein kinase tousled-like 2 (TLK2) | Co-Target | ||||
UniProt ID | TLK2_HUMAN | |||||
Gene Name | TLK2 | |||||
Synonyms |
HsHPK; PKU-alpha; Tousled-like kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.66 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 9-Cyclin T2 complex (CDK9-CCNT2) | Co-Target | ||||
UniProt ID | CDK9_HUMAN-CCNT2_HUMAN | |||||
Gene Name | CDK9-CCNT2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 3.77 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin A complex (CDK2-CCNA2) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNA1_HUMAN/CCNA2_HUMAN | |||||
Gene Name | CDK2-CCNA1/CCNA2 | |||||
Representative Drug(s) | Staurosporine | Drug Info | Ki = 4 nM | [47] | ||
Co-Target Name | Serine/threonine-protein kinase MRCK beta (CDC42BPB) | Co-Target | ||||
UniProt ID | MRCKB_HUMAN | |||||
Gene Name | CDC42BPB | |||||
Synonyms |
CDC42-binding protein kinase beta; CDC42BP-beta; DMPK-like beta; Myotonic dystrophy kinase-related CDC42-binding kinase beta; MRCK beta; Myotonic dystrophy protein kinase-like beta
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.75 nM | [1] | ||
Co-Target Name | CaM kinase I beta (PNCK) | Co-Target | ||||
UniProt ID | KCC1B_HUMAN | |||||
Gene Name | PNCK | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type 1B; CaM kinase IB; CaM-KI beta; CaMKI-beta; Pregnancy up-regulated non-ubiquitously-expressed CaM kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 4.99 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 5 (PAK5) | Co-Target | ||||
UniProt ID | PAK5_HUMAN | |||||
Gene Name | PAK5 | |||||
Synonyms |
p21-activated kinase 5; PAK-5; p21-activated kinase 7; PAK-7
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.3 nM | [1] | ||
Co-Target Name | CaM kinase I gamma (CAMK1G) | Co-Target | ||||
UniProt ID | KCC1G_HUMAN | |||||
Gene Name | CAMK1G | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type 1G; CaM kinase IG; CaM-KI gamma; CaMKI gamma; CaMKIG; CaMK-like CREB kinase III; CLICK III
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.34 nM | [1] | ||
Co-Target Name | G protein-coupled receptor kinase 7 (GRK7) | Co-Target | ||||
UniProt ID | GRK7_HUMAN | |||||
Gene Name | GRK7 | |||||
Synonyms |
Rhodopsin kinase GRK7; G protein-coupled receptor kinase GRK7
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 5.96 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 8-Cyclin C complex (CDK8-CCNC) | Co-Target | ||||
UniProt ID | CDK8_HUMAN-CCNC_HUMAN | |||||
Gene Name | CDK8-CCNC | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6 nM | [48] | ||
Co-Target Name | Myosin IIIB (MYO3B) | Co-Target | ||||
UniProt ID | MYO3B_HUMAN | |||||
Gene Name | MYO3B | |||||
Synonyms |
Myosin-IIIb
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.4 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 4-G1/S specific cyclin D1 complex (CDK4-CCND1) | Co-Target | ||||
UniProt ID | CDK4_HUMAN-CCND1_HUMAN | |||||
Gene Name | CDK4-CCND1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.6 nM | [44] | ||
Co-Target Name | cAMP-dependent protein kinase gamma (PRKACG) | Co-Target | ||||
UniProt ID | KAPCG_HUMAN | |||||
Gene Name | PRKACG | |||||
Synonyms |
cAMP-dependent protein kinase catalytic subunit gamma; PKA C-gamma
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 6.8 nM | [1] | ||
Co-Target Name | Testis-specific serine/threonine-protein kinase 3 (TSSK3) | Co-Target | ||||
UniProt ID | TSSK3_HUMAN | |||||
Gene Name | TSSK3 | |||||
Synonyms |
TSK-3; TSSK-3; Testis-specific kinase 3; Serine/threonine-protein kinase 22C
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 7.01 nM | [1] | ||
Co-Target Name | Death-associated protein kinase 2 (DAPK2) | Co-Target | ||||
UniProt ID | DAPK2_HUMAN | |||||
Gene Name | DAPK2 | |||||
Synonyms |
DAP kinase 2; DAP-kinase-related protein 1; DRP-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 7.25 nM | [1] | ||
Co-Target Name | Mitogen-activated protein kinase 15 (MAPK15) | Co-Target | ||||
UniProt ID | MK15_HUMAN | |||||
Gene Name | MAPK15 | |||||
Synonyms |
MAP kinase 15; MAPK 15; Extracellular signal-regulated kinase 7; ERK-7; Extracellular signal-regulated kinase 8; ERK-8
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 7.3 nM | [3] | ||
Co-Target Name | SNF-related serine/threonine-protein kinase (SNRK) | Co-Target | ||||
UniProt ID | SNRK_HUMAN | |||||
Gene Name | SNRK | |||||
Synonyms |
SNF1-related kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 8.01 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase 10 (STK10) | Co-Target | ||||
UniProt ID | STK10_HUMAN | |||||
Gene Name | STK10 | |||||
Synonyms |
Lymphocyte-oriented kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 9.01 nM | [1] | ||
Co-Target Name | Ribosomal protein S6 kinase alpha 4 (RPS6KA4) | Co-Target | ||||
UniProt ID | KS6A4_HUMAN | |||||
Gene Name | RPS6KA4 | |||||
Synonyms |
Ribosomal protein S6 kinase alpha-4; S6K-alpha-4; 90 kDa ribosomal protein S6 kinase 4; Nuclear mitogen- and stress-activated protein kinase 2; Ribosomal protein kinase B; RSKB
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11.3 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase TAO2 (TAOK2) | Co-Target | ||||
UniProt ID | TAOK2_HUMAN | |||||
Gene Name | TAOK2 | |||||
Synonyms |
Kinase from chicken homolog C; hKFC-C; Prostate-derived sterile 20-like kinase 1; PSK-1; PSK1; Prostate-derived STE20-like kinase 1; Thousand and one amino acid protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 11.7 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase LATS1 (LATS1) | Co-Target | ||||
UniProt ID | LATS1_HUMAN | |||||
Gene Name | LATS1 | |||||
Synonyms |
Large tumor suppressor homolog 1; WARTS protein kinase; h-warts
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 12.8 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 9-Cyclin K complex (CDK9-CCNK) | Co-Target | ||||
UniProt ID | CDK9_HUMAN-CCNK_HUMAN | |||||
Gene Name | CDK9-CCNK | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 13 nM | [44] | ||
Co-Target Name | Insulin receptor-related protein (INSRR) | Co-Target | ||||
UniProt ID | INSRR_HUMAN | |||||
Gene Name | INSRR | |||||
Synonyms |
IRR; IR-related receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 15 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 6-G1/S specific cyclin D3 complex (CDK6-CCND2) | Co-Target | ||||
UniProt ID | CDK6_HUMAN-CCND3_HUMAN | |||||
Gene Name | CDK6-CCND3 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 15.4 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 17-Cyclin Y complex (CDK17-CCNY) | Co-Target | ||||
UniProt ID | CDK17_HUMAN-CCNY_HUMAN | |||||
Gene Name | CDK17-CCNY | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 16.3 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Sgk2 (SGK2) | Co-Target | ||||
UniProt ID | SGK2_HUMAN | |||||
Gene Name | SGK2 | |||||
Synonyms |
Serum/glucocorticoid-regulated kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 16.5 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase FRK (FRK) | Co-Target | ||||
UniProt ID | FRK_HUMAN | |||||
Gene Name | FRK | |||||
Synonyms |
FYN-related kinase; Nuclear tyrosine protein kinase RAK; Protein-tyrosine kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 17 nM | [1] | ||
Co-Target Name | Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3) | Co-Target | ||||
UniProt ID | MP2K3_HUMAN | |||||
Gene Name | MAP2K3 | |||||
Synonyms |
MAP kinase kinase 3; MAPKK 3; MAPK/ERK kinase 3; MEK 3; Stress-activated protein kinase kinase 2; SAPK kinase 2; SAPKK-2; SAPKK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 17.2 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase haspin (HASPIN) | Co-Target | ||||
UniProt ID | HASP_HUMAN | |||||
Gene Name | HASPIN | |||||
Synonyms |
Germ cell-specific gene 2 protein; H-haspin; Haploid germ cell-specific nuclear protein kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 19 nM | [41] | ||
Co-Target Name | Serine/threonine-protein kinase tousled-like 1 (TLK1) | Co-Target | ||||
UniProt ID | TLK1_HUMAN | |||||
Gene Name | TLK1 | |||||
Synonyms |
PKU-beta; Tousled-like kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 21.7 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 16-Cyclin Y complex (CDK16-CCNY) | Co-Target | ||||
UniProt ID | CDK16_HUMAN-CCNY_HUMAN | |||||
Gene Name | CDK16-CCNY | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 24 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase 17B (STK17B) | Co-Target | ||||
UniProt ID | ST17B_HUMAN | |||||
Gene Name | STK17B | |||||
Synonyms |
DAP kinase-related apoptosis-inducing protein kinase 2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 25.8 nM | [23] | ||
Co-Target Name | Serine/threonine-protein kinase MAK (MAK) | Co-Target | ||||
UniProt ID | MAK_HUMAN | |||||
Gene Name | MAK | |||||
Synonyms |
Male germ cell-associated kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 28.7 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PAK 6 (PAK6) | Co-Target | ||||
UniProt ID | PAK6_HUMAN | |||||
Gene Name | PAK6 | |||||
Synonyms |
PAK-5; p21-activated kinase 6; PAK-6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 31 nM | [1] | ||
Co-Target Name | TGF-beta-activated kinase 1-binding protein 1 (TAB1) | Co-Target | ||||
UniProt ID | TAB1_HUMAN | |||||
Gene Name | TAB1 | |||||
Synonyms |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TAK1-binding protein 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 35 nM | [4] | ||
Co-Target Name | Cyclin dependent kinase 4-G1/S-specific cyclin-D3 complex (CDK4-CCND3) | Co-Target | ||||
UniProt ID | CDK4_HUMAN-CCND3_HUMAN | |||||
Gene Name | CDK4-CCND3 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 37.1 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase ICK (CILK1) | Co-Target | ||||
UniProt ID | CILK1_HUMAN | |||||
Gene Name | CILK1 | |||||
Synonyms |
Ciliogenesis associated kinase 1; Intestinal cell kinase; hICK; Laryngeal cancer kinase 2; LCK2; MAK-related kinase; MRK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 41.06 nM | [3] | ||
Co-Target Name | Myosin IIIA (MYO3A) | Co-Target | ||||
UniProt ID | MYO3A_HUMAN | |||||
Gene Name | MYO3A | |||||
Synonyms |
Myosin-IIIa
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 44.8 nM | [1] | ||
Co-Target Name | CDC7-related kinase-Protein DBF4 homolog A (CDC7-DBF4) | Co-Target | ||||
UniProt ID | CDC7_HUMAN; DBF4A_HUMAN | |||||
Gene Name | CDC7; DBF4 | |||||
Synonyms |
Cell division cycle 7 related protein kinase-Activator of S phase kinase; Cell division cycle 7 related protein kinase-DBF4-type zinc finger-containing protein 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 46.3 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 18-Cyclin Y complex (CDK18-CCNY) | Co-Target | ||||
UniProt ID | CDK18_HUMAN-CCNY_HUMAN | |||||
Gene Name | CDK18-CCNY | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 51.1 nM | [1] | ||
Co-Target Name | Myosin light chain kinase 4 (MYLK4) | Co-Target | ||||
UniProt ID | MYLK4_HUMAN | |||||
Gene Name | MYLK4 | |||||
Synonyms |
Myosin light chain kinase family member 4; Sugen kinase 85; SgK085
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 52.9 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 12-Cyclin K complex (CDK12-CCNK) | Co-Target | ||||
UniProt ID | CDK12_HUMAN-CCNK_HUMAN | |||||
Gene Name | CDK12-CCNK | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 53 nM | [49] | ||
Co-Target Name | Cyclin dependent kinase 13-Cyclin K complex (CDK13-CCNK) | Co-Target | ||||
UniProt ID | CDK13_HUMAN-CCNK_HUMAN | |||||
Gene Name | CDK13-CCNK | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 57 nM | [49] | ||
Co-Target Name | Rhodopsin kinase (GRK1) | Co-Target | ||||
UniProt ID | GRK1_HUMAN | |||||
Gene Name | GRK1 | |||||
Synonyms |
G protein-coupled receptor kinase 1; Rhodopsin kinase GRK1; RK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 57.8 nM | [1] | ||
Co-Target Name | Protein odd-skipped-related 1 (OSR1) | Co-Target | ||||
UniProt ID | OSR1_HUMAN | |||||
Gene Name | OSR1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 61.3 nM | [1] | ||
Co-Target Name | G protein-coupled receptor kinase 6 (GRK6) | Co-Target | ||||
UniProt ID | GRK6_HUMAN | |||||
Gene Name | GRK6 | |||||
Synonyms |
G protein-coupled receptor kinase GRK6
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 61.7 nM | [1] | ||
Co-Target Name | Dual serine/threonine and tyrosine protein kinase (DSTYK) | Co-Target | ||||
UniProt ID | DUSTY_HUMAN | |||||
Gene Name | DSTYK | |||||
Synonyms |
Dusty protein kinase; Dusty PK; RIP-homologous kinase; Receptor-interacting serine/threonine-protein kinase 5; Sugen kinase 496; SgK496
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 65.2 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2) | Co-Target | ||||
UniProt ID | ERN2_HUMAN | |||||
Gene Name | ERN2 | |||||
Synonyms |
Endoplasmic reticulum-to-nucleus signaling 2; Inositol-requiring protein 2; hIRE2p; Ire1-beta; IRE1b
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 65.8 nM | [1] | ||
Co-Target Name | Retinoblastoma-associated protein (RB1) | Co-Target | ||||
UniProt ID | RB_HUMAN | |||||
Gene Name | RB1 | |||||
Synonyms |
p110-RB1; p105-Rb; pRb; Rb; pp110
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 66 nM | [50] | ||
Co-Target Name | Serine/threonine-protein kinase 11 (STK11) | Co-Target | ||||
UniProt ID | STK11_HUMAN | |||||
Gene Name | STK11 | |||||
Synonyms |
Serine/threonine-protein kinase STK11; Liver kinase B1; LKB1; hLKB1; Renal carcinoma antigen NY-REN-19
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 70.9 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Sgk3 (SGK3) | Co-Target | ||||
UniProt ID | SGK3_HUMAN | |||||
Gene Name | SGK3 | |||||
Synonyms |
Cytokine-independent survival kinase; Serum/glucocorticoid-regulated kinase 3; Serum/glucocorticoid-regulated kinase-like
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 76.5 nM | [1] | ||
Co-Target Name | CDK7-Cyclin H-CDK activating kinase assembly factor MAT1 complex (CDK7-CCNH-MNAT1) | Co-Target | ||||
UniProt ID | CDK7_HUMAN-CCNH_HUMAN-MAT1_HUMAN | |||||
Gene Name | CDK7-CCNH-MNAT1 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 76.6 nM | [1] | ||
Co-Target Name | Serine/threonine protein kinase NLK (NLK) | Co-Target | ||||
UniProt ID | NLK_HUMAN | |||||
Gene Name | NLK | |||||
Synonyms |
Serine/threonine-protein kinase NLK; Nemo-like kinase; Protein LAK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 77.8 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Nek4 (NEK4) | Co-Target | ||||
UniProt ID | NEK4_HUMAN | |||||
Gene Name | NEK4 | |||||
Synonyms |
Never in mitosis A-related kinase 4; NimA-related protein kinase 4; Serine/threonine-protein kinase 2; Serine/threonine-protein kinase NRK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 96 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Nek5 (NEK5) | Co-Target | ||||
UniProt ID | NEK5_HUMAN | |||||
Gene Name | NEK5 | |||||
Synonyms |
Never in mitosis A-related kinase 5; NimA-related protein kinase 5
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 96.5 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase SBK1 (SBK1) | Co-Target | ||||
UniProt ID | SBK1_HUMAN | |||||
Gene Name | SBK1 | |||||
Synonyms |
SH3-binding kinase 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 99.8 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 14-Cyclin Y complex (CDK14-CCNY) | Co-Target | ||||
UniProt ID | CDK14_HUMAN-CCNY_HUMAN | |||||
Gene Name | CDK14-CCNY | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 101 nM | [1] | ||
Co-Target Name | Myotonin-protein kinase (DMPK) | Co-Target | ||||
UniProt ID | DMPK_HUMAN | |||||
Gene Name | DMPK | |||||
Synonyms |
MT-PK; DM-kinase; DMK; DM1 protein kinase; DMPK; Myotonic dystrophy protein kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 105 nM | [1] | ||
Co-Target Name | G protein-coupled receptor kinase 4 (GRK4) | Co-Target | ||||
UniProt ID | GRK4_HUMAN | |||||
Gene Name | GRK4 | |||||
Synonyms |
G protein-coupled receptor kinase GRK4; ITI1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 113 nM | [1] | ||
Co-Target Name | Myosin light chain kinase 3 (MYLK3) | Co-Target | ||||
UniProt ID | MYLK3_HUMAN | |||||
Gene Name | MYLK3 | |||||
Synonyms |
Cardiac-MyBP-C-associated Ca/CaM kinase; Cardiac-MLCK
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 129 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase NIM1 (NIM1K) | Co-Target | ||||
UniProt ID | NIM1_HUMAN | |||||
Gene Name | NIM1K | |||||
Synonyms |
NIM1 serine/threonine-protein kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 129 nM | [1] | ||
Co-Target Name | CaM kinase IV (CAMK4) | Co-Target | ||||
UniProt ID | KCC4_HUMAN | |||||
Gene Name | CAMK4 | |||||
Synonyms |
Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaM kinase-GR
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 157 nM | [1] | ||
Co-Target Name | MAP kinase p38 delta (MAPK13) | Co-Target | ||||
UniProt ID | MK13_HUMAN | |||||
Gene Name | MAPK13 | |||||
Synonyms |
Mitogen-activated protein kinase 13; MAP kinase 13; MAPK 13; Mitogen-activated protein kinase p38 delta; Stress-activated protein kinase 4
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 160 nM | [1] | ||
Co-Target Name | Mitogen-activated protein kinase kinase kinase 12 (MAP3K12) | Co-Target | ||||
UniProt ID | M3K12_HUMAN | |||||
Gene Name | MAP3K12 | |||||
Synonyms |
Dual leucine zipper bearing kinase; DLK; Leucine-zipper protein kinase; ZPK; MAPK-upstream kinase; MUK; Mixed lineage kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 180 nM | [1] | ||
Co-Target Name | Testis-specific serine/threonine-protein kinase 6 (TSSK6) | Co-Target | ||||
UniProt ID | TSSK6_HUMAN | |||||
Gene Name | TSSK6 | |||||
Synonyms |
TSK-6; TSSK-6; Testis-specific kinase 6; Cancer/testis antigen 72; CT72; Serine/threonine-protein kinase SSTK; Small serine/threonine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 193 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase PLK3 (PLK3) | Co-Target | ||||
UniProt ID | PLK3_HUMAN | |||||
Gene Name | PLK3 | |||||
Synonyms |
Cytokine-inducible serine/threonine-protein kinase; FGF-inducible kinase; Polo-like kinase 3; PLK-3; Proliferation-related kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 224 nM | [1] | ||
Co-Target Name | Homeodomain-interacting protein kinase 4 (HIPK4) | Co-Target | ||||
UniProt ID | HIPK4_HUMAN | |||||
Gene Name | HIPK4 | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 314 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase RIPK2 (RIPK2) | Co-Target | ||||
UniProt ID | RIPK2_HUMAN | |||||
Gene Name | RIPK2 | |||||
Synonyms |
Receptor-interacting serine/threonine-protein kinase 2; CARD-containing interleukin-1 beta-converting enzyme-associated kinase; CARD-containing IL-1 beta ICE-kinase; RIP-like-interacting CLARP kinase; Receptor-interacting protein 2; RIP-2; Tyrosine-protein kinase RIPK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 317 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase 32C (STK32C) | Co-Target | ||||
UniProt ID | ST32C_HUMAN | |||||
Gene Name | STK32C | |||||
Synonyms |
PKE; Yet another novel kinase 3
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 325 nM | [1] | ||
Co-Target Name | Tyrosine-protein kinase CTK (MATK) | Co-Target | ||||
UniProt ID | MATK_HUMAN | |||||
Gene Name | MATK | |||||
Synonyms |
Megakaryocyte-associated tyrosine-protein kinase; CSK homologous kinase; CHK; Hematopoietic consensus tyrosine-lacking kinase; Protein kinase HYL
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 492 nM | [1] | ||
Co-Target Name | Homeodomain-interacting protein kinase 3 (HIPK3) | Co-Target | ||||
UniProt ID | HIPK3_HUMAN | |||||
Gene Name | HIPK3 | |||||
Synonyms |
Androgen receptor-interacting nuclear protein kinase; ANPK; Fas-interacting serine/threonine-protein kinase; FIST; Homolog of protein kinase YAK1
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 710 nM | [1] | ||
Co-Target Name | Serine/threonine-protein kinase Nek11 (NEK11) | Co-Target | ||||
UniProt ID | NEK11_HUMAN | |||||
Gene Name | NEK11 | |||||
Synonyms |
Never in mitosis A-related kinase 11; NimA-related protein kinase 11
Click to Show/Hide
|
|||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 752 nM | [1] | ||
Co-Target Name | Cyclin dependent kinase 7-Cyclin H complex (CDK7-CCNH) | Co-Target | ||||
UniProt ID | CDK7_HUMAN-CCNH_HUMAN | |||||
Gene Name | CDK7-CCNH | |||||
Representative Drug(s) | Staurosporine | Drug Info | IC50 = 910 nM | [44] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. Eur J Med Chem. 2019 Jan 1;161:456-467. | ||||
REF 2 | Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4720-3. | ||||
REF 3 | Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders. Eur J Med Chem. 2017 Dec 1;141:657-675. | ||||
REF 4 | Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem. 2009 May 28;52(10):3191-204. | ||||
REF 5 | Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly. Bioorg Med Chem Lett. 2012 Jan 1;22(1):591-6. | ||||
REF 6 | Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping. J Med Chem. 2017 Jun 8;60(11):4636-56. | ||||
REF 7 | Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors. Bioorg Med Chem. 2016 Aug 15;24(16):3483-93. | ||||
REF 8 | Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. J Med Chem. 2017 Nov 22;60(22):9205-9221. | ||||
REF 9 | Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors. Eur J Med Chem. 2011 Sep;46(9):4311-23. | ||||
REF 10 | Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4163-8. | ||||
REF 11 | Biochemical characterization of a novel type-II VEGFR2 kinase inhibitor: comparison of binding to non-phosphorylated and phosphorylated VEGFR2. Bioorg Med Chem. 2011 Sep 15;19(18):5342-51. | ||||
REF 12 | Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors. Eur J Med Chem. 2015 Sep 18;102:600-10. | ||||
REF 13 | Structural basis for the inhibitor recognition of human Lyn kinase domain. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6557-60. | ||||
REF 14 | Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3. Bioorg Med Chem Lett. 2003 Sep 15;13(18):3049-53. | ||||
REF 15 | Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinases. J Med Chem. 2004 Nov 18;47(24):5894-911. | ||||
REF 16 | Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs. Eur J Med Chem. 2017 Feb 15;127:442-58. | ||||
REF 17 | Novel 8-arylated purines as inhibitors of glycogen synthase kinase. Eur J Med Chem. 2010 Aug;45(8):3389-93. | ||||
REF 18 | Design, synthesis, and biological activity of phenyl-pyrazole derivatives as BCR-ABL kinase inhibitors. Bioorg Med Chem. 2015 Jul 1;23(13):3147-52. | ||||
REF 19 | Molecular docking study on anticancer activity of plant-derived natural products. Med Chem Res. 2009 Jul 28;19:817-35. | ||||
REF 20 | Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer. Bioorg Med Chem Lett. 2006 Apr 1;16(7):2000-7. | ||||
REF 21 | From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells. J Med Chem. 2009 Apr 9;52(7):1853-63. | ||||
REF 22 | Bioactive Indolocarbazoles from the Marine-Derived Streptomyces sp. DT-A61. J Nat Prod. 2018 Apr 27;81(4):949-956. | ||||
REF 23 | Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3beta inhibitors and neuroprotective agents. Bioorg Med Chem. 2015 Mar 1;23(5):1179-88. | ||||
REF 24 | Purpuroines A-J, halogenated alkaloids from the sponge Iotrochota purpurea with antibiotic activity and regulation of tyrosine kinases. Bioorg Med Chem. 2012 Dec 15;20(24):6924-8. | ||||
REF 25 | Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyro... J Med Chem. 2002 Aug 15;45(17):3772-93. | ||||
REF 26 | Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors. Bioorg Med Chem. 2014 Sep 1;22(17):4855-66. | ||||
REF 27 | The development of CNS-active LRRK2 inhibitors using property-directed optimisation. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3690-6. | ||||
REF 28 | Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy. Eur J Med Chem. 2017 May 5;131:1-13. | ||||
REF 29 | Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3835-9. | ||||
REF 30 | Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer. Bioorg Med Chem. 2017 Apr 1;25(7):2156-2166. | ||||
REF 31 | Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1). J Med Chem. 2002 Jan 17;45(2):529-32. | ||||
REF 32 | Design, synthesis and biological evaluation of pyrazol-furan carboxamide analogues as novel Akt kinase inhibitors. Eur J Med Chem. 2016 Jul 19;117:47-58. | ||||
REF 33 | Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode. J Med Chem. 2009 Apr 9;52(7):1814-27. | ||||
REF 34 | Novel indolocarbazole protein kinase c inhibitors with improved biochemical and physicochemical properties. Bioorg Med Chem Lett. 1995 Jan 5;5(1):55-60. | ||||
REF 35 | Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases. J Med Chem. 2014 Jun 26;57(12):5011-22. | ||||
REF 36 | Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors. J Nat Prod. 2018 Apr 27;81(4):998-1006. | ||||
REF 37 | Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2. Eur J Med Chem. 2015 Oct 20;103:29-43. | ||||
REF 38 | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-beta type I receptor kinase as cancer immunotherapeutic/antifibrotic agent. J Med Chem. 2014 May 22;57(10):4213-38. | ||||
REF 39 | Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett. 2011 Jul 1;21(13):4108-14. | ||||
REF 40 | Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum. J Nat Prod. 2014 Jan 24;77(1):49-56. | ||||
REF 41 | Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone. Eur J Med Chem. 2019 Feb 1;163:453-480. | ||||
REF 42 | Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1679-85. | ||||
REF 43 | Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IkappaB kinase-beta. Eur J Med Chem. 2011 Apr;46(4):1245-53. | ||||
REF 44 | Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases. J Med Chem. 2013 May 23;56(10):3768-82. | ||||
REF 45 | Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides. J Med Chem. 1992 Jan;35(1):177-84. | ||||
REF 46 | Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells. Bioorg Med Chem. 2011 Nov 15;19(22):6760-7. | ||||
REF 47 | Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity. J Med Chem. 2013 Feb 14;56(3):660-70. | ||||
REF 48 | Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening. Eur J Med Chem. 2017 Mar 31;129:275-286. | ||||
REF 49 | Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. J Med Chem. 2018 Sep 13;61(17):7710-7728. | ||||
REF 50 | Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors. Eur J Med Chem. 2017 Jul 7;134:366-378. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.